[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"_public_publisher_byId_4c3d4859-5c58-45e9-8f80-6cfbf1f66820":3,"_public_publication_all{\"sortAscending\":false,\"sortField\":\"updateTime\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"publisherId:4c3d4859-5c58-45e9-8f80-6cfbf1f66820,\"}":92},{"code":4,"data":5,"meta":18},"SUCCESS",{"id":6,"createTime":7,"updateTime":8,"relativeEntities":9,"slug":10,"properties":11,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":20,"manageAffiliations":45,"indexDatabases":53,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},"4c3d4859-5c58-45e9-8f80-6cfbf1f66820","2023-12-05T05:27:59.837+00:00","2025-11-21T09:47:26.375+00:00",[],"The-Breast",{"issn":12,"title":14},{"VOID":13},"09609776",{"EN":15},"The Breast","PUBLISHER","PENDING",null,0,[21,27,33,39],{"id":22,"createTime":18,"updateTime":18,"relativeEntities":23,"label":24,"description":26,"parentId":18,"standard":18,"scholarHubFieldId":18},"f3c7480d-9f85-464a-ad0d-807993a45c26",[],{"EN":25},"Surgery",{},{"id":28,"createTime":18,"updateTime":18,"relativeEntities":29,"label":30,"description":32,"parentId":18,"standard":18,"scholarHubFieldId":18},"740fbbd4-0204-4499-bc5d-be3ba61fc9be",[],{"EN":31},"Cancer Research",{},{"id":34,"createTime":18,"updateTime":18,"relativeEntities":35,"label":36,"description":38,"parentId":18,"standard":18,"scholarHubFieldId":18},"d9687dc3-fd83-46ff-aef4-1925044c24eb",[],{"EN":37},"Oncology",{},{"id":40,"createTime":18,"updateTime":18,"relativeEntities":41,"label":42,"description":44,"parentId":18,"standard":18,"scholarHubFieldId":18},"0254e3e5-c28d-4a33-83da-81bc94d29ffd",[],{"EN":43},"Medicine (miscellaneous)",{},[46],{"id":47,"createTime":18,"updateTime":18,"relativeEntities":48,"slug":18,"properties":49,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":52,"statistic":18},"353f4a78-4364-4142-a6fb-e8ac89c7d65e",[],{"title":50},{"EN":51},"Churchill Livingstone",[],[54,72],{"id":55,"indexDatabase":56,"url":68,"indexYears":18,"academicFieldIds":69,"indexDatabaseRanking":18},"25099711-1f39-4fb5-adb8-3be301acda3f",{"id":57,"createTime":18,"updateTime":18,"relativeEntities":58,"label":59,"description":61,"key":64,"publicationTags":65,"standard":18},"a4921856-b128-4d9f-8f1f-e80813d3bbd4",[],{"EN":60,"VI":60},"ISI\u002FSCIE - Science Citation Index Expanded",{"EN":62,"VI":63},"SCIE database","Cơ sở dữ liệu SCIE","scie",[66,67],"SCIE","ISI","https:\u002F\u002Fmjl.clarivate.com\u002Fsearch-results?issn=0960-9776",[70,71],"248e54de-c562-4c06-8a10-d7f8a37c06fe","373912bc-55c0-410a-8280-da8a470d15e2",{"id":73,"indexDatabase":74,"url":84,"indexYears":85,"academicFieldIds":86,"indexDatabaseRanking":91},"a781f2e9-6848-429b-92b3-f8515a6194fe",{"id":75,"createTime":18,"updateTime":18,"relativeEntities":76,"label":77,"description":79,"key":81,"publicationTags":82,"standard":18},"3c7051d4-eb7d-4c57-a56b-36fc74c5d1e9",[],{"EN":78,"VI":78},"Scopus - Elsevier",{"EN":78,"VI":80},"Cơ sở dữ liệu Scopus thuộc Elsevier","scopus",[83],"SCOPUS","https:\u002F\u002Fwww.scopus.com\u002Fsourceid\u002F12595","1992-2025",[87,88,89,90],"d729cb0b-d468-4829-9bfc-9e3b992eeefe","e89cebf4-fecf-4b74-8ab4-88fca891e4c2","ee505398-b96f-423d-82ed-9f73f07d49d4","462e3fe4-4fc0-4c02-80d6-8d2af4fc74ea","SCOPUS__Q1",{"meta":93,"data":95},{"total":94},"1751",[96,400,517,686,789,1195,1334,1738,2074,2301],{"id":97,"createTime":98,"updateTime":99,"relativeEntities":100,"slug":101,"properties":102,"entityType":109,"verifyStatus":110,"verifyTime":111,"verifyNote":112,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":113,"fullTextUrl":18,"authors":114,"publicationType":265,"publisherRelationship":266,"citationCount":315,"citationInfo":316,"publishDate":319,"publishYear":317,"citationAnalyzeStatus":320,"lastCitationAnalyze":321,"indexDatabases":322,"openAccess":18,"references":323,"isForceReanalyzing":399},"74ac2b0b-c84e-4302-80a1-37e7e9e9aee0","2023-12-06T11:48:04.271+00:00","2026-07-29T08:47:23.103+00:00",[],"Pain-during-vacuum-assisted-breast-biopsy-Are-there-any-predictors-",{"title":103,"gsPaper":105,"doi":107},{"EN":104},"Pain during vacuum-assisted breast biopsy: Are there any predictors?",{"VOID":106},"[\"16719549115080894131\"]",{"VOID":108},"10.1016\u002Fj.breast.2008.06.002","PUBLICATION","VERIFIED","2024-05-07T17:25:01.732+00:00","Auto Verify","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0960977608001525",[115,133,149,165,181,195,209,223,237,251],{"id":116,"sortIndex":19,"researcher":18,"roles":117,"affiliations":119,"properties":128,"displayName":130,"givenName":18,"familyName":18},"8392ca27-281d-4504-a20a-dcc5b5d30f71",[118],"AUTHOR",[120],{"id":121,"sortIndex":19,"affiliation":122,"properties":18},"e8baa4f6-1e1c-45d0-89e4-37705b9a2f72",{"id":121,"createTime":18,"updateTime":18,"relativeEntities":123,"slug":18,"properties":124,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":127,"statistic":18},[],{"title":125},{"VI":126},"Breast Unit, 1st Department of Propaedeutic Surgery, Hippokratio Hospital, University of Athens, 114 Vas Sofias Avenue, Athens 116 27, Greece",[],{"title":129,"gsAuthor":131},{"VI":130},"George C. Zografos",{"VOID":132},"[\"3zRLuG8AAAAJ\"]",{"id":134,"sortIndex":135,"researcher":18,"roles":136,"affiliations":137,"properties":144,"displayName":146,"givenName":18,"familyName":18},"72d1a9c8-32a5-4f38-83ed-61b1e4314977",1,[118],[138],{"id":121,"sortIndex":19,"affiliation":139,"properties":18},{"id":121,"createTime":18,"updateTime":18,"relativeEntities":140,"slug":18,"properties":141,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":143,"statistic":18},[],{"title":142},{"VI":126},[],{"title":145,"gsAuthor":147},{"VI":146},"Flora Zagouri",{"VOID":148},"[\"XKsBaLAAAAAJ\"]",{"id":150,"sortIndex":151,"researcher":18,"roles":152,"affiliations":153,"properties":160,"displayName":162,"givenName":18,"familyName":18},"e65b0887-fdfb-4d63-b4eb-203fa9064308",2,[118],[154],{"id":121,"sortIndex":19,"affiliation":155,"properties":18},{"id":121,"createTime":18,"updateTime":18,"relativeEntities":156,"slug":18,"properties":157,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":159,"statistic":18},[],{"title":158},{"VI":126},[],{"title":161,"gsAuthor":163},{"VI":162},"Theodoros N. Sergentanis",{"VOID":164},"[\"NXfZa6AAAAAJ\"]",{"id":166,"sortIndex":167,"researcher":18,"roles":168,"affiliations":169,"properties":176,"displayName":178,"givenName":18,"familyName":18},"e1fc379c-9d48-4e94-b035-77566fca1981",3,[118],[170],{"id":121,"sortIndex":19,"affiliation":171,"properties":18},{"id":121,"createTime":18,"updateTime":18,"relativeEntities":172,"slug":18,"properties":173,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":175,"statistic":18},[],{"title":174},{"VI":126},[],{"title":177,"gsAuthor":179},{"VI":178},"Afrodite Nonni",{"VOID":180},"[\"X8K5jhoAAAAJ\"]",{"id":182,"sortIndex":183,"researcher":18,"roles":184,"affiliations":185,"properties":192,"displayName":194,"givenName":18,"familyName":18},"518b2118-a176-4c0a-93e7-8861c98a2dc5",4,[118],[186],{"id":121,"sortIndex":19,"affiliation":187,"properties":18},{"id":121,"createTime":18,"updateTime":18,"relativeEntities":188,"slug":18,"properties":189,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":191,"statistic":18},[],{"title":190},{"VI":126},[],{"title":193},{"VI":194},"Philip Domeyer",{"id":196,"sortIndex":197,"researcher":18,"roles":198,"affiliations":199,"properties":206,"displayName":208,"givenName":18,"familyName":18},"2a2092eb-d5ec-4f82-b12f-e5857f213b90",5,[118],[200],{"id":121,"sortIndex":19,"affiliation":201,"properties":18},{"id":121,"createTime":18,"updateTime":18,"relativeEntities":202,"slug":18,"properties":203,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":205,"statistic":18},[],{"title":204},{"VI":126},[],{"title":207},{"VI":208},"Dimitra Koulocheri",{"id":210,"sortIndex":211,"researcher":18,"roles":212,"affiliations":213,"properties":220,"displayName":222,"givenName":18,"familyName":18},"51b8fb28-cd71-4074-8eb4-a3d24119f10a",6,[118],[214],{"id":121,"sortIndex":19,"affiliation":215,"properties":18},{"id":121,"createTime":18,"updateTime":18,"relativeEntities":216,"slug":18,"properties":217,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":219,"statistic":18},[],{"title":218},{"VI":126},[],{"title":221},{"VI":222},"Ioannis Flessas",{"id":224,"sortIndex":225,"researcher":18,"roles":226,"affiliations":227,"properties":234,"displayName":236,"givenName":18,"familyName":18},"ba27aaf0-a5bb-4531-8b30-8672661440dd",7,[118],[228],{"id":121,"sortIndex":19,"affiliation":229,"properties":18},{"id":121,"createTime":18,"updateTime":18,"relativeEntities":230,"slug":18,"properties":231,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":233,"statistic":18},[],{"title":232},{"VI":126},[],{"title":235},{"VI":236},"Effrosyni Panopoulou",{"id":238,"sortIndex":239,"researcher":18,"roles":240,"affiliations":241,"properties":248,"displayName":250,"givenName":18,"familyName":18},"ce5047bb-2e79-47fa-ad74-a52c53332940",8,[118],[242],{"id":121,"sortIndex":19,"affiliation":243,"properties":18},{"id":121,"createTime":18,"updateTime":18,"relativeEntities":244,"slug":18,"properties":245,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":247,"statistic":18},[],{"title":246},{"VI":126},[],{"title":249},{"VI":250},"Dimosthenis Chrysikos",{"id":252,"sortIndex":253,"researcher":18,"roles":254,"affiliations":255,"properties":262,"displayName":264,"givenName":18,"familyName":18},"a20ccf76-3941-4f7d-8b7d-18077d7628e6",9,[118],[256],{"id":121,"sortIndex":19,"affiliation":257,"properties":18},{"id":121,"createTime":18,"updateTime":18,"relativeEntities":258,"slug":18,"properties":259,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":261,"statistic":18},[],{"title":260},{"VI":126},[],{"title":263},{"VI":264},"John Bramis","ARTICLE",{"url":113,"publisher":267,"properties":310},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":268,"slug":10,"properties":269,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":272,"manageAffiliations":289,"indexDatabases":295,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":270,"title":271},{"VOID":13},{"EN":15},[273,277,281,285],{"id":22,"createTime":18,"updateTime":18,"relativeEntities":274,"label":275,"description":276,"parentId":18,"standard":18,"scholarHubFieldId":18},[],{"EN":25},{},{"id":28,"createTime":18,"updateTime":18,"relativeEntities":278,"label":279,"description":280,"parentId":18,"standard":18,"scholarHubFieldId":18},[],{"EN":31},{},{"id":34,"createTime":18,"updateTime":18,"relativeEntities":282,"label":283,"description":284,"parentId":18,"standard":18,"scholarHubFieldId":18},[],{"EN":37},{},{"id":40,"createTime":18,"updateTime":18,"relativeEntities":286,"label":287,"description":288,"parentId":18,"standard":18,"scholarHubFieldId":18},[],{"EN":43},{},[290],{"id":47,"createTime":18,"updateTime":18,"relativeEntities":291,"slug":18,"properties":292,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":294,"statistic":18},[],{"title":293},{"EN":51},[],[296,303],{"id":55,"indexDatabase":297,"url":68,"indexYears":18,"academicFieldIds":302,"indexDatabaseRanking":18},{"id":57,"createTime":18,"updateTime":18,"relativeEntities":298,"label":299,"description":300,"key":64,"publicationTags":301,"standard":18},[],{"EN":60,"VI":60},{"EN":62,"VI":63},[66,67],[70,71],{"id":73,"indexDatabase":304,"url":84,"indexYears":85,"academicFieldIds":309,"indexDatabaseRanking":91},{"id":75,"createTime":18,"updateTime":18,"relativeEntities":305,"label":306,"description":307,"key":81,"publicationTags":308,"standard":18},[],{"EN":78,"VI":78},{"EN":78,"VI":80},[83],[87,88,89,90],{"pages":311,"volume":313},{"VOID":312},"592-595",{"VOID":314},"17",15,{"total":315,"publishYear":317,"statisticByYear":318},2008,{"2009":151,"2010":135,"2011":135,"2013":135,"2014":151,"2015":135,"2018":135,"2019":135,"2020":151,"2025":167},"2008-12-01","DONE_ANALYZE_CITATION","2026-07-29T08:47:23.102+00:00",[66,91],[324,330,334,340,346,349,355,358,364,370,376,379,385,393],{"id":325,"text":326,"url":327,"identifiers":328},"f9241c5e-6a26-4079-a279-ad2458d74be5","Kettritz, 2005, Stereotactic vacuum-assisted breast biopsies in 500 women with microcalcifications: radiological and pathological correlations, Eur J Radiol, 55, 270, 10.1016\u002Fj.ejrad.2004.10.014","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0720048X04003560",{"doi":329},"10.1016\u002Fj.ejrad.2004.10.014",{"id":18,"text":331,"url":18,"identifiers":332},"Hoorntje, 2003, Vacuum-assisted breast-biopsy: a critical review, Eur J Cancer, 39, 1676, 10.1016\u002FS0959-8049(03)00421-0",{"doi":333},"10.1016\u002FS0959-8049(03)00421-0",{"id":335,"text":336,"url":337,"identifiers":338},"8e388688-efd0-4a84-9644-476006a52bd1","Zagouri, 2008, Pain in different methods of breast biopsy: emphasis on vacuum-assisted breast biopsy, Breast, 17, 71, 10.1016\u002Fj.breast.2007.07.039","https:\u002F\u002Flinkinghub.elsevier.com\u002Fretrieve\u002Fpii\u002FS0960977607001555",{"doi":339},"10.1016\u002Fj.breast.2007.07.039",{"id":341,"text":342,"url":343,"identifiers":344},"4c877e59-2f80-47a4-b56a-e7c32495d2d8","Folstein, 1975, “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician, J Psychiatr Res, 12, 189, 10.1016\u002F0022-3956(75)90026-6","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002F0022395675900266",{"doi":345},"10.1016\u002F0022-3956(75)90026-6",{"id":18,"text":347,"url":18,"identifiers":348},"Spitzer, 1979",{},{"id":350,"text":351,"url":352,"identifiers":353},"4c68646b-0035-4279-8000-0006b275d4fa","Lai, 2000, Vacuum-assisted large-core breast biopsy: complications and their incidence, Can Assoc Radiol J, 51, 232","https:\u002F\u002Flink.springer.com\u002F10.1007\u002Fs10440-022-00541-7",{"doi":354},"10.1007\u002Fs10440-022-00541-7",{"id":350,"text":356,"url":352,"identifiers":357},"Ceccarelli, 2005, Non palpable lesions of the breast: the Mammotome-biopsy in the preoperative management of breast cancer, G Chir, 26, 187",{"doi":354},{"id":359,"text":360,"url":361,"identifiers":362},"ea9d7aac-101f-4e43-a172-2015b47424b9","Hemmer, 2008, Stereotactic large-core needle breast biopsy: analysis of pain and discomfort related to the biopsy procedure, Eur Radiol, 18, 351, 10.1007\u002Fs00330-007-0762-3","https:\u002F\u002Flink.springer.com\u002Farticle\u002F10.1007\u002Fs00330-007-0762-3",{"doi":363},"10.1007\u002Fs00330-007-0762-3",{"id":365,"text":366,"url":367,"identifiers":368},"b41ac8a0-6cdf-4561-a3df-e525088f9020","Zografos, 2008, What parameters affect pain in core biopsy?, Eur Radiol, 10.1007\u002Fs00330-008-0879-z","https:\u002F\u002Flink.springer.com\u002Farticle\u002F10.1007\u002Fs00330-008-0879-z",{"doi":369},"10.1007\u002Fs00330-008-0879-z",{"id":371,"text":372,"url":373,"identifiers":374},"f3e7213a-7f8c-4e1c-95e6-ab574c2df8dd","Zografos, 2008, Predictors of pain during open breast biopsy under local anesthesia: is there such a thing?, Pain Pract, 8, 151, 10.1111\u002Fj.1533-2500.2008.00183.x","https:\u002F\u002Fonlinelibrary.wiley.com\u002Fdoi\u002F10.1111\u002Fj.1533-2500.2008.00183.x",{"doi":375},"10.1111\u002Fj.1533-2500.2008.00183.x",{"id":350,"text":377,"url":352,"identifiers":378},"Zografos, 2007, Minimizing underestimation rate of microcalcifications excised via vacuum-assisted breast biopsy: a blind study, Breast Cancer Res Treat",{"doi":354},{"id":380,"text":381,"url":382,"identifiers":383},"37604962-5270-42e8-a2f1-9bbaf601c0f4","Zografos, 2007, Is zero underestimation feasible? Extended vacuum-assisted breast biopsy in solid lesions – a blind study, World J Surg Oncol, 5, 53, 10.1186\u002F1477-7819-5-53","https:\u002F\u002Fwjso.biomedcentral.com\u002Farticles\u002F10.1186\u002F1477-7819-5-53",{"doi":384},"10.1186\u002F1477-7819-5-53",{"id":18,"text":386,"url":387,"identifiers":388},"Zografos, 2008, Lobular neoplasia in vacuum-assisted breast biopsy: extended protocols and underestimation, Am J Roentgenol, 190, W272, 10.2214\u002FAJR.07.3264","https:\u002F\u002Fdoi.org\u002F10.2214\u002Fajr.07.3264",{"mag":389,"openalex":390,"pm":391,"doi":392},"2067648368","W2067648368","18356422","10.2214\u002Fajr.07.3264",{"id":394,"text":395,"url":396,"identifiers":397},"80ee4c04-ea3a-45bf-81bc-16ffe11cd4bc","Zagouri, 2008, Atypical ductal hyperplasia: a way to minimize underestimation in vacuum-assisted breast biopsy?, Breast, 17, 6, 10.1016\u002Fj.breast.2007.10.002","https:\u002F\u002Flinkinghub.elsevier.com\u002Fretrieve\u002Fpii\u002FS0960977607002226",{"doi":398},"10.1016\u002Fj.breast.2007.10.002",false,{"id":401,"createTime":402,"updateTime":403,"relativeEntities":404,"slug":405,"properties":406,"entityType":109,"verifyStatus":110,"verifyTime":415,"verifyNote":112,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":416,"fullTextUrl":18,"authors":417,"publicationType":265,"publisherRelationship":461,"citationCount":510,"citationInfo":511,"publishDate":514,"publishYear":512,"citationAnalyzeStatus":320,"lastCitationAnalyze":515,"indexDatabases":516,"openAccess":18,"references":18,"isForceReanalyzing":399},"62f4b36a-c71b-4169-8112-69009e34bfaa","2024-01-27T01:11:39.964+00:00","2026-07-25T22:55:45.729+00:00",[],"Kylie-Minogue-s-breast-cancer-Effects-on-referrals-to-a-rapid-access-breast-clinic-in-the-UK",{"title":407,"gsPaper":409,"references":411,"doi":413},{"EN":408},"Kylie Minogue's breast cancer: Effects on referrals to a rapid access breast clinic in the UK",{"VOID":410},"[\"10960365110708467115\"]",{"VOID":412},"Chapman, 2005, Impact of news of celebrity illness on breast cancer screening: Kylie Minogue's breast cancer diagnosis, Med J Aust, 183, 247, 10.5694\u002Fj.1326-5377.2005.tb07029.x\nHelfenstein, 1991, The use of transfer function models, intervention analysis and related time series methods in epidemiology, Int J Epidemiol, 20, 808, 10.1093\u002Fije\u002F20.3.808\nNattinger, 1998, Effect of Nancy Reagan's mastectomy on choice of surgery for breast cancer by US women, JAMA, 279, 762, 10.1001\u002Fjama.279.10.762\nBerrington de Gonzalez, 2005, Mammographic screening before age 50 years in the UK: comparison of the radiation risks with the mortality benefits, Br J Cancer, 93, 590, 10.1038\u002Fsj.bjc.6602683\nBrett, 2005, The psychological impact of mammographic screening. A systematic review, Psychooncology, 14, 917, 10.1002\u002Fpon.904",{"VOID":414},"10.1016\u002Fj.breast.2006.03.006","2024-06-24T07:57:49.990+00:00","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0960977606000737",[418,435,448],{"id":419,"sortIndex":19,"researcher":18,"roles":420,"affiliations":421,"properties":430,"displayName":432,"givenName":18,"familyName":18},"0d7a3187-9efd-4b42-a3cf-ebc47b6ecf81",[118],[422],{"id":423,"sortIndex":19,"affiliation":424,"properties":18},"afec76c5-1106-429f-a10c-8e7787257f7c",{"id":423,"createTime":18,"updateTime":18,"relativeEntities":425,"slug":18,"properties":426,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":429,"statistic":18},[],{"title":427},{"VI":428},"Breast Unit, Department of General Surgery, Royal Gwent Hospital, Cardiff road, Newport, South Wales NP20 2UB, UK",[],{"title":431,"gsAuthor":433},{"VI":432},"C. Twine",{"VOID":434},"[\"A9A7HvYAAAAJ\"]",{"id":436,"sortIndex":135,"researcher":18,"roles":437,"affiliations":438,"properties":445,"displayName":447,"givenName":18,"familyName":18},"62972c7c-9874-4fdb-a395-69baee841b74",[118],[439],{"id":423,"sortIndex":19,"affiliation":440,"properties":18},{"id":423,"createTime":18,"updateTime":18,"relativeEntities":441,"slug":18,"properties":442,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":444,"statistic":18},[],{"title":443},{"VI":428},[],{"title":446},{"VI":447},"L. Barthelmes",{"id":449,"sortIndex":151,"researcher":18,"roles":450,"affiliations":451,"properties":458,"displayName":460,"givenName":18,"familyName":18},"ae0c84a9-3ccf-4943-a6b7-76d909090102",[118],[452],{"id":423,"sortIndex":19,"affiliation":453,"properties":18},{"id":423,"createTime":18,"updateTime":18,"relativeEntities":454,"slug":18,"properties":455,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":457,"statistic":18},[],{"title":456},{"VI":428},[],{"title":459},{"VI":460},"C.A. Gateley",{"url":416,"publisher":462,"properties":505},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":463,"slug":10,"properties":464,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":467,"manageAffiliations":484,"indexDatabases":490,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":465,"title":466},{"VOID":13},{"EN":15},[468,472,476,480],{"id":22,"createTime":18,"updateTime":18,"relativeEntities":469,"label":470,"description":471,"parentId":18,"standard":18,"scholarHubFieldId":18},[],{"EN":25},{},{"id":28,"createTime":18,"updateTime":18,"relativeEntities":473,"label":474,"description":475,"parentId":18,"standard":18,"scholarHubFieldId":18},[],{"EN":31},{},{"id":34,"createTime":18,"updateTime":18,"relativeEntities":477,"label":478,"description":479,"parentId":18,"standard":18,"scholarHubFieldId":18},[],{"EN":37},{},{"id":40,"createTime":18,"updateTime":18,"relativeEntities":481,"label":482,"description":483,"parentId":18,"standard":18,"scholarHubFieldId":18},[],{"EN":43},{},[485],{"id":47,"createTime":18,"updateTime":18,"relativeEntities":486,"slug":18,"properties":487,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":489,"statistic":18},[],{"title":488},{"EN":51},[],[491,498],{"id":55,"indexDatabase":492,"url":68,"indexYears":18,"academicFieldIds":497,"indexDatabaseRanking":18},{"id":57,"createTime":18,"updateTime":18,"relativeEntities":493,"label":494,"description":495,"key":64,"publicationTags":496,"standard":18},[],{"EN":60,"VI":60},{"EN":62,"VI":63},[66,67],[70,71],{"id":73,"indexDatabase":499,"url":84,"indexYears":85,"academicFieldIds":504,"indexDatabaseRanking":91},{"id":75,"createTime":18,"updateTime":18,"relativeEntities":500,"label":501,"description":502,"key":81,"publicationTags":503,"standard":18},[],{"EN":78,"VI":78},{"EN":78,"VI":80},[83],[87,88,89,90],{"pages":506,"volume":508},{"VOID":507},"667-669",{"VOID":509},"15",41,{"total":510,"publishYear":512,"statisticByYear":513},2006,{"2006":135,"2008":183,"2009":151,"2010":135,"2011":151,"2013":135,"2014":239,"2015":183,"2016":197,"2017":151,"2018":135,"2019":135,"2020":151,"2022":151,"2023":135,"2024":151},"2006-10-01","2026-07-25T22:55:45.728+00:00",[66,91],{"id":518,"createTime":519,"updateTime":520,"relativeEntities":521,"slug":522,"properties":523,"entityType":109,"verifyStatus":110,"verifyTime":532,"verifyNote":112,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":533,"fullTextUrl":18,"authors":534,"publicationType":265,"publisherRelationship":630,"citationCount":679,"citationInfo":680,"publishDate":684,"publishYear":681,"citationAnalyzeStatus":320,"lastCitationAnalyze":520,"indexDatabases":685,"openAccess":18,"references":18,"isForceReanalyzing":399},"7248cec0-381f-4fab-8112-b5e1ddd1792b","2024-01-08T15:50:09.311+00:00","2026-07-25T14:01:50.053+00:00",[],"Prognostic-role-of-caveolin-in-breast-cancer-A-meta-analysis",{"title":524,"gsPaper":526,"references":528,"doi":530},{"EN":525},"Prognostic role of caveolin in breast cancer: A meta-analysis",{"VOID":527},"[\"8085043788879853694\"]",{"VOID":529},"Jemal, 2011, Global cancer statistics, CA Cancer J Clin, 61, 69, 10.3322\u002Fcaac.20107\nGluz, 2009, Triple-negative breast cancer–current status and future directions, Ann Oncol, 20, 1913, 10.1093\u002Fannonc\u002Fmdp492\nYamashiro, 2008, Update of evidence in chemotherapy for breast cancer, Int J Clin Oncol, 13, 3, 10.1007\u002Fs10147-007-0719-1\nParolini, 1999, Expression of caveolin-1 is required for the transport of caveolin-2 to the plasma membrane. Retention of caveolin-2 at the level of the golgi complex, J Biol Chem, 274, 25718, 10.1074\u002Fjbc.274.36.25718\nHnasko, 2003, The biology of caveolae: lessons from caveolin knockout mice and implications for human disease, Mol Interv, 3, 445, 10.1124\u002Fmi.3.8.445\nWitkiewicz, 2010, Loss of stromal caveolin-1 expression predicts poor clinical outcome in triplenegative and basal-like breast cancers, Cancer Biol Ther, 10, 135, 10.4161\u002Fcbt.10.2.11983\nSotgia, 2006, Genetic ablation of caveolin-1 in mammary epithelial cells increases milk production and hyper-activates STAT5a signaling, Cancer Biol Ther, 5, 292, 10.4161\u002Fcbt.5.3.2390\nQian, 2010, Is dysfunction of caveolin-1 a link between systemic sclerosis and breast cancer, opening a window on both etiologies, Arch Med Res, 41, 297, 10.1016\u002Fj.arcmed.2010.05.009\nWilliams, 2006, Stromal and epithelial caveolin-1 both confer a protective effect against mammary hyperplasia and tumorigenesis: caveolin-1 antagonizes cyclin D1 function in mammary epithelial cells, Am J Pathol, 169, 1784, 10.2353\u002Fajpath.2006.060590\nLiedtke, 2007, Caveolin-1 expression in benign and malignant lesions of the breast, World J Surg Oncol, 5, 110, 10.1186\u002F1477-7819-5-110\nQian, 2011, Prognostic significance of tumor\u002Fstromal caveolin-1 expression in breast cancerpatients, Cancer Sci, 102, 1590, 10.1111\u002Fj.1349-7006.2011.01985.x\nParmar, 1998, Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints, Stat Med, 17, 2815, 10.1002\u002F(SICI)1097-0258(19981230)17:24\u003C2815::AID-SIM110>3.0.CO;2-8\nWilliamson, 2002, Aggregate data meta-analysis with time-to-event outcomes, Stat Med, 21, 3337, 10.1002\u002Fsim.1303\nTierney, 2007, Practical methods for incorporating summary time-to-event data into meta-analysis, Trials, 8, 16, 10.1186\u002F1745-6215-8-16\nCornfield, 1951, A method of estimating comparative rates from clinical data; applications to cancer of the lung, breast, and cervix, J Natl Cancer Inst, 11, 1269\nHiggins, 2003, Measuring inconsistency in meta-analyses, BMJ, 327, 557, 10.1136\u002Fbmj.327.7414.557\nBegg CB. Publication bias 1994;299:25.\nCharpin, 2009, A signature predictive of disease outcome in breast carcinomas, identified byquantitative immunocytochemical assays, Int J Cancer, 124, 2124, 10.1002\u002Fijc.24177\nEl-Gendi, 2011, Stromal caveolin-1 expression in breast carcinoma. Correlation with early tumor recurrence and clinical outcome, Pathol Oncol Res\nElsheikh, 2008, Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like andtriple-negative immunophenotype, Br J Cancer, 99, 327, 10.1038\u002Fsj.bjc.6604463\nGarcia, 2007, Poor prognosis in breast carcinomas correlates with increased expression of targetable CD146 and c-Met and with proteomic basal-like phenotype, Hum Pathol, 38, 830, 10.1016\u002Fj.humpath.2006.11.015\nJoshi, 2008, Phosphorylated caveolin-1 regulates Rho\u002FROCK-dependent focal adhesion dynamics and tumor cell migration and invasion, Cancer Res, 68, 8210, 10.1158\u002F0008-5472.CAN-08-0343\nKoo, 2011, The impact of caveolin protein expression in tumor stroma on prognosis of breast cancer, Tumour Biol, 32, 787, 10.1007\u002Fs13277-011-0181-6\nMercier, 2009, Using Caveolin-1 epithelial immunostaining patterns to stratify human breastcancer patients and predict the Caveolin-1 (P132L) mutation, Cell Cycle, 8, 1396, 10.4161\u002Fcc.8.9.8307\nSavage, 2007, Caveolin 1 is overexpressed and amplified in a subset of basal-like and metaplastic breast carcinomas: a morphologic, ultrastructural, immunohistochemical, and in situ hybridization analysis, Clin Cancer Res, 13, 90, 10.1158\u002F1078-0432.CCR-06-1371\nSavage, 2008, Distribution and significance of caveolin 2 expression in normal breast and invasive breast cancer: an immunofluorescence and immunohistochemical analysis, Breast Cancer Res Treat, 110, 245, 10.1007\u002Fs10549-007-9718-1\nSloan, 2009, Stromal cell expression of caveolin-1 predicts outcome in breast cancer, Am J Pathol, 174, 2035, 10.2353\u002Fajpath.2009.080924\nWitkiewicz, 2009, Stromal caveolin-1 levels predict early DCIS progression to invasive breastcancer, Cancer Biol Ther, 8, 1071, 10.4161\u002Fcbt.8.11.8874\nWitkiewicz, 2009, An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers, Am J Pathol, 174, 2023, 10.2353\u002Fajpath.2009.080873\nPark, 2005, Caveolin-1 is down-regulated and inversely correlated with HER2 and EGFR expression status in invasive ductal carcinoma of the breast, Histopathology, 47, 625, 10.1111\u002Fj.1365-2559.2005.02303.x\nPinilla, 2006, Caveolin-1 expression is associated with a basal-like phenotype in sporadic andhereditary breast cancer, Breast Cancer Res Treat, 99, 85, 10.1007\u002Fs10549-006-9184-1\nSagara, 2004, Clinical significance of Caveolin-1, Caveolin-2 and HER2\u002Fneu mRNA expression inhuman breast cancer, Br J Cancer, 91, 959, 10.1038\u002Fsj.bjc.6602029\nYang, 1998, Elevated expression of caveolin is associated with prostate and breast cancer, Clin Cancer Res, 4, 1873\nLi, 2006, Caveolin-1 mutations in human breast cancer: functional association with estrogen receptor alpha-positive status, Am J Pathol, 168, 1998, 10.2353\u002Fajpath.2006.051089\nLiu, 2011, Significant association of caveolin-1 (CAV1) genotypes with breast cancer in Taiwan, Anticancer Res, 31, 3511\nPerrone, 2009, Caveolin-1 expression in human breast lobular cancer progression, Mod Pathol, 22, 71, 10.1038\u002Fmodpathol.2008.154\nWitkiewicz, 2009, Towards a new \"stromal-based\" classification system for human breast cancer prognosis and therapy, Cell Cycle, 8, 1654, 10.4161\u002Fcc.8.11.8544\nHayes, 2001, Prognostic factors in breast cancer: current and new predictors of metastasis, J Mammary Gland Biol Neoplasia, 6, 375, 10.1023\u002FA:1014778713034\nSotgia, 2012, Caveolin-1 and cancer metabolism in the tumor microenvironment: markers, models, and mechanisms, Annu Rev Pathol, 7, 423, 10.1146\u002Fannurev-pathol-011811-120856\nBhowmick, 2004, Stromal fibroblasts in cancer initiation and progression, Nature, 432, 332, 10.1038\u002Fnature03096\nMercier, 2008, Human breast cancer-associated fibroblasts (CAFs) show caveolin-1 downregulation and RB tumor suppressor functional inactivation: Implications for the response to hormonal therapy, Cancer Biol Ther, 7, 1212, 10.4161\u002Fcbt.7.8.6220\nOrimo, 2006, Stromal fibroblasts in cancer: a novel tumor-promoting cell type, Cell Cycle, 5, 1597, 10.4161\u002Fcc.5.15.3112\nXie, 2003, Transformation of mammary epithelial cells by 3-phosphoinositide-dependent protein kinase-1 activates beta-catenin and c-Myc, and down-regulates caveolin-1, Cancer Res, 63, 5370",{"VOID":531},"10.1016\u002Fj.breast.2013.03.005","2024-06-24T07:06:17.589+00:00","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS096097761300060X",[535,552,565,578,591,604,617],{"id":536,"sortIndex":19,"researcher":18,"roles":537,"affiliations":538,"properties":547,"displayName":549,"givenName":18,"familyName":18},"6e1bacf3-d796-400e-95a4-27d666e23499",[118],[539],{"id":540,"sortIndex":19,"affiliation":541,"properties":18},"55a86dbb-54b2-4af4-8330-8c3fb04a891a",{"id":540,"createTime":18,"updateTime":18,"relativeEntities":542,"slug":18,"properties":543,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":546,"statistic":18},[],{"title":544},{"VI":545},"Department of Medical Oncology, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China",[],{"title":548,"gsAuthor":550},{"VI":549},"Xuelei Ma",{"VOID":551},"[\"nKScpQYAAAAJ\"]",{"id":553,"sortIndex":135,"researcher":18,"roles":554,"affiliations":555,"properties":562,"displayName":564,"givenName":18,"familyName":18},"4bfbdf7e-2c34-4dbd-9fd2-78a1333d4474",[118],[556],{"id":540,"sortIndex":19,"affiliation":557,"properties":18},{"id":540,"createTime":18,"updateTime":18,"relativeEntities":558,"slug":18,"properties":559,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":561,"statistic":18},[],{"title":560},{"VI":545},[],{"title":563},{"VI":564},"Lei Liu",{"id":566,"sortIndex":151,"researcher":18,"roles":567,"affiliations":568,"properties":575,"displayName":577,"givenName":18,"familyName":18},"e55268b0-bdd5-49a4-9b7a-69d31b48ad13",[118],[569],{"id":540,"sortIndex":19,"affiliation":570,"properties":18},{"id":540,"createTime":18,"updateTime":18,"relativeEntities":571,"slug":18,"properties":572,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":574,"statistic":18},[],{"title":573},{"VI":545},[],{"title":576},{"VI":577},"Wen Nie",{"id":579,"sortIndex":167,"researcher":18,"roles":580,"affiliations":581,"properties":588,"displayName":590,"givenName":18,"familyName":18},"e0dff6dc-241e-406e-8547-a54b2af788f3",[118],[582],{"id":540,"sortIndex":19,"affiliation":583,"properties":18},{"id":540,"createTime":18,"updateTime":18,"relativeEntities":584,"slug":18,"properties":585,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":587,"statistic":18},[],{"title":586},{"VI":545},[],{"title":589},{"VI":590},"Yanyan Li",{"id":592,"sortIndex":183,"researcher":18,"roles":593,"affiliations":594,"properties":601,"displayName":603,"givenName":18,"familyName":18},"30dcdbde-2ab7-473d-8635-0a78afba3e9f",[118],[595],{"id":540,"sortIndex":19,"affiliation":596,"properties":18},{"id":540,"createTime":18,"updateTime":18,"relativeEntities":597,"slug":18,"properties":598,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":600,"statistic":18},[],{"title":599},{"VI":545},[],{"title":602},{"VI":603},"Binglan Zhang",{"id":605,"sortIndex":197,"researcher":18,"roles":606,"affiliations":607,"properties":614,"displayName":616,"givenName":18,"familyName":18},"9f5be1ea-ff6e-43b4-89e1-c512bd51cefc",[118],[608],{"id":540,"sortIndex":19,"affiliation":609,"properties":18},{"id":540,"createTime":18,"updateTime":18,"relativeEntities":610,"slug":18,"properties":611,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":613,"statistic":18},[],{"title":612},{"VI":545},[],{"title":615},{"VI":616},"Jing Zhang",{"id":618,"sortIndex":211,"researcher":18,"roles":619,"affiliations":620,"properties":627,"displayName":629,"givenName":18,"familyName":18},"a2d66b28-2389-43ca-a582-2c62f27f5f72",[118],[621],{"id":540,"sortIndex":19,"affiliation":622,"properties":18},{"id":540,"createTime":18,"updateTime":18,"relativeEntities":623,"slug":18,"properties":624,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":626,"statistic":18},[],{"title":625},{"VI":545},[],{"title":628},{"VI":629},"Rubai Zhou",{"url":533,"publisher":631,"properties":674},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":632,"slug":10,"properties":633,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":636,"manageAffiliations":653,"indexDatabases":659,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":634,"title":635},{"VOID":13},{"EN":15},[637,641,645,649],{"id":22,"createTime":18,"updateTime":18,"relativeEntities":638,"label":639,"description":640,"parentId":18,"standard":18,"scholarHubFieldId":18},[],{"EN":25},{},{"id":28,"createTime":18,"updateTime":18,"relativeEntities":642,"label":643,"description":644,"parentId":18,"standard":18,"scholarHubFieldId":18},[],{"EN":31},{},{"id":34,"createTime":18,"updateTime":18,"relativeEntities":646,"label":647,"description":648,"parentId":18,"standard":18,"scholarHubFieldId":18},[],{"EN":37},{},{"id":40,"createTime":18,"updateTime":18,"relativeEntities":650,"label":651,"description":652,"parentId":18,"standard":18,"scholarHubFieldId":18},[],{"EN":43},{},[654],{"id":47,"createTime":18,"updateTime":18,"relativeEntities":655,"slug":18,"properties":656,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":658,"statistic":18},[],{"title":657},{"EN":51},[],[660,667],{"id":55,"indexDatabase":661,"url":68,"indexYears":18,"academicFieldIds":666,"indexDatabaseRanking":18},{"id":57,"createTime":18,"updateTime":18,"relativeEntities":662,"label":663,"description":664,"key":64,"publicationTags":665,"standard":18},[],{"EN":60,"VI":60},{"EN":62,"VI":63},[66,67],[70,71],{"id":73,"indexDatabase":668,"url":84,"indexYears":85,"academicFieldIds":673,"indexDatabaseRanking":91},{"id":75,"createTime":18,"updateTime":18,"relativeEntities":669,"label":670,"description":671,"key":81,"publicationTags":672,"standard":18},[],{"EN":78,"VI":78},{"EN":78,"VI":80},[83],[87,88,89,90],{"pages":675,"volume":677},{"VOID":676},"462-469",{"VOID":678},"22",47,{"total":679,"publishYear":681,"statisticByYear":682},2013,{"2014":211,"2015":683,"2016":167,"2017":211,"2018":167,"2019":211,"2020":183,"2021":151,"2023":167,"2024":135,"2025":151},11,"2013-08-01",[66,91],{"id":687,"createTime":688,"updateTime":689,"relativeEntities":690,"slug":691,"properties":692,"entityType":109,"verifyStatus":110,"verifyTime":701,"verifyNote":112,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":702,"fullTextUrl":18,"authors":703,"publicationType":265,"publisherRelationship":734,"citationCount":19,"citationInfo":783,"publishDate":786,"publishYear":784,"citationAnalyzeStatus":17,"lastCitationAnalyze":787,"indexDatabases":788,"openAccess":18,"references":18,"isForceReanalyzing":399},"6f3620aa-d3b5-4466-811c-65c5d5d06532","2023-12-11T12:58:19.875+00:00","2026-07-23T07:34:02.900+00:00",[],"Antibody-drug-conjugates-targeting-Trop-2-Clinical-developments-in-early-breast-cancer-therapy",{"title":693,"gsPaper":695,"references":697,"doi":699},{"EN":694},"Antibody-drug conjugates targeting Trop-2: Clinical developments in early breast cancer therapy",{"VOID":696},"[\"10507143455827493882\"]",{"VOID":698},"Bardia, 2019, Sacituzumab govitecan-hziy in refractory metastatic triple-negative breast cancer, N Engl J Med., 380, 741, 10.1056\u002FNEJMoa1814213\nAmbrogi, 2014, Trop-2 is a determinant of breast cancer survival, PLoS One, 9, 10.1371\u002Fjournal.pone.0096993\nLin, 2013, Significantly upregulated TACSTD2 and Cyclin D1 correlate with poor prognosis of invasive ductal breast cancer, Exp Mol Pathol., 94, 73, 10.1016\u002Fj.yexmp.2012.08.004\nBardia, 2021, Sacituzumab govitecan in metastatic triple-negative breast cancer, N Engl J Med., 384, 1529, 10.1056\u002FNEJMoa2028485\nKrop, 2022, Datopotamab deruxtecan in advanced\u002Fmetastatic HER2- breast cancer: results from the phase 1 TROPION-PanTumor01 study, Cancer Res., 82, 10.1158\u002F1538-7445.SABCS21-GS1-05\nTagawa, 2021, TROPHY-U-01: a phase II open-label study of sacituzumab govitecan in patients with metastatic urothelial carcinoma progressing after platinum-based chemotherapy and checkpoint inhibitors, J Clin Oncol., 39, 2474, 10.1200\u002FJCO.20.03489\nMasuda, 2017, Adjuvant capecitabine for breast cancer after preoperative chemotherapy, N Engl J Med., 376, 2147, 10.1056\u002FNEJMoa1612645\nSchmid, 2022, Event-free survival with pembrolizumab in early triple-negative breast cancer, N Engl J Med., 386, 556, 10.1056\u002FNEJMoa2112651\nTutt, 2021, Adjuvant olaparib for patients with BRCA1- or BRCA2-mutated breast cancer, N Engl J Med., 384, 2394, 10.1056\u002FNEJMoa2105215\nvon Minckwitz, 2019, Trastuzumab emtansine for residual invasive HER2-positive breast cancer, N Engl J Med., 380, 617, 10.1056\u002FNEJMoa1814017\nRugo, 2022, Sacituzumab govitecan in hormone receptor-positive\u002Fhuman epidermal growth factor receptor 2-negative metastatic breast cancer, J Clin Oncol., 40, 3365, 10.1200\u002FJCO.22.01002\n2020\nTrodelvy\nStarodub, 2015, First-in-Human trial of a novel anti-trop-2 antibody-SN-38 conjugate, sacituzumab govitecan, for the treatment of diverse metastatic solid tumors, Clin Cancer Res., 21, 3870, 10.1158\u002F1078-0432.CCR-14-3321\nCardillo, 2017, Abstract 3193: treatment of high Trop-2-expressing triple-negative breast cancer (TNBC) with sacituzumab govitecan (IMMU-132) overcomes homologous recombination repair (HRR) rescue mediated by Rad51, Cancer Res., 77, 3193, 10.1158\u002F1538-7445.AM2017-3193\nCardillo, 2011, Humanized anti-Trop-2 IgG-SN-38 conjugate for effective treatment of diverse epithelial cancers: preclinical studies in human cancer xenograft models and monkeys, Clin Cancer Res., 17, 3157, 10.1158\u002F1078-0432.CCR-10-2939\nGoldenberg, 2018, The emergence of trophoblast cell-surface antigen 2 (TROP-2) as a novel cancer target, Oncotarget, 9, 28989, 10.18632\u002Foncotarget.25615\nPerrone, 2020, Sacituzumab govitecan, an antibody-drug conjugate targeting trophoblast cell-surface antigen 2, shows cytotoxic activity against poorly differentiated endometrial adenocarcinomas in vitro and in vivo, Mol Oncol., 14, 645, 10.1002\u002F1878-0261.12627\nStaudacher, 2017, Antibody drug conjugates and bystander killing: is antigen-dependent internalisation required?, Br J Cancer, 117, 1736, 10.1038\u002Fbjc.2017.367\nMathijssen, 2001, Clinical pharmacokinetics and metabolism of irinotecan (CPT-11), Clin Cancer Res., 7, 2182\nSharkey, 2015, Enhanced delivery of SN-38 to human tumor xenografts with an anti-trop-2-SN-38 antibody conjugate (sacituzumab govitecan), Clin Cancer Res., 21, 5131, 10.1158\u002F1078-0432.CCR-15-0670\nKopp, 2022, Antibody drug conjugate sacituzumab govitecan drives efficient tissue penetration and rapid intracellular drug release, Mol Cancer Ther., 10.1158\u002F1535-7163.MCT-22-0375\nThomas, 2016, Antibody-drug conjugates for cancer therapy, Lancet Oncol., 17, e254, 10.1016\u002FS1470-2045(16)30030-4\nOcean, 2017, Sacituzumab govitecan (IMMU-132), an anti-Trop-2-SN-38 antibody-drug conjugate for the treatment of diverse epithelial cancers: safety and pharmacokinetics, Cancer, 123, 3843, 10.1002\u002Fcncr.30789\nGoldenberg, 2015, Trop-2 is a novel target for solid cancer therapy with sacituzumab govitecan (IMMU-132), an antibody-drug conjugate (ADC), Oncotarget, 6, 22496, 10.18632\u002Foncotarget.4318\nMarmé, 2022, Safety interim analysis of the phase III postneoadjuvant SASCIA study evaluating sacituzumab govitecan in patients with primary HER2-negative breast cancer at high relapse risk after neoadjuvant treatment, Ann Oncol., 33, S148, 10.1016\u002Fj.annonc.2022.03.074\nMayer, 2021, Randomized phase III postoperative trial of platinum-based chemotherapy versus capecitabine in patients with residual triple-negative breast cancer following neoadjuvant chemotherapy: ecog-ACRIN EA1131, J Clin Oncol., 39, 2539, 10.1200\u002FJCO.21.00976\nSpring, 2022, Phase 2 study of response-guided neoadjuvant sacituzumab govitecan (IMMU-132) in patients with localized triple-negative breast cancer: results from the NeoSTAR trial, J Clin Oncol, 40, 10.1200\u002FJCO.2022.40.16_suppl.512\nMedford, 2021, Antibody drug conjugates for patients with breast cancer, Curr Probl Cancer, 45, 10.1016\u002Fj.currproblcancer.2021.100795",{"VOID":700},"10.1016\u002Fj.breast.2022.10.015","2024-06-23T10:13:50.080+00:00","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0960977622001801",[704,721],{"id":705,"sortIndex":19,"researcher":18,"roles":706,"affiliations":707,"properties":716,"displayName":718,"givenName":18,"familyName":18},"801e56fb-0c2f-4766-a2c5-ebbd08c6e22b",[118],[708],{"id":709,"sortIndex":19,"affiliation":710,"properties":18},"00eac8a6-3f98-464b-a106-56a2966b4fa9",{"id":709,"createTime":18,"updateTime":18,"relativeEntities":711,"slug":18,"properties":712,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":715,"statistic":18},[],{"title":713},{"VI":714},"Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea",[],{"title":717,"gsAuthor":719},{"VI":718},"Jae Ho Jeong",{"VOID":720},"[\"KcBAGaIAAAAJ\"]",{"id":722,"sortIndex":135,"researcher":18,"roles":723,"affiliations":724,"properties":731,"displayName":733,"givenName":18,"familyName":18},"9eeb7288-4e79-4864-9f4a-14079eb7d00b",[118],[725],{"id":709,"sortIndex":19,"affiliation":726,"properties":18},{"id":709,"createTime":18,"updateTime":18,"relativeEntities":727,"slug":18,"properties":728,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":730,"statistic":18},[],{"title":729},{"VI":714},[],{"title":732},{"VI":733},"Sung-Bae Kim",{"url":702,"publisher":735,"properties":778},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":736,"slug":10,"properties":737,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":740,"manageAffiliations":757,"indexDatabases":763,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":738,"title":739},{"VOID":13},{"EN":15},[741,745,749,753],{"id":22,"createTime":18,"updateTime":18,"relativeEntities":742,"label":743,"description":744,"parentId":18,"standard":18,"scholarHubFieldId":18},[],{"EN":25},{},{"id":28,"createTime":18,"updateTime":18,"relativeEntities":746,"label":747,"description":748,"parentId":18,"standard":18,"scholarHubFieldId":18},[],{"EN":31},{},{"id":34,"createTime":18,"updateTime":18,"relativeEntities":750,"label":751,"description":752,"parentId":18,"standard":18,"scholarHubFieldId":18},[],{"EN":37},{},{"id":40,"createTime":18,"updateTime":18,"relativeEntities":754,"label":755,"description":756,"parentId":18,"standard":18,"scholarHubFieldId":18},[],{"EN":43},{},[758],{"id":47,"createTime":18,"updateTime":18,"relativeEntities":759,"slug":18,"properties":760,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":762,"statistic":18},[],{"title":761},{"EN":51},[],[764,771],{"id":55,"indexDatabase":765,"url":68,"indexYears":18,"academicFieldIds":770,"indexDatabaseRanking":18},{"id":57,"createTime":18,"updateTime":18,"relativeEntities":766,"label":767,"description":768,"key":64,"publicationTags":769,"standard":18},[],{"EN":60,"VI":60},{"EN":62,"VI":63},[66,67],[70,71],{"id":73,"indexDatabase":772,"url":84,"indexYears":85,"academicFieldIds":777,"indexDatabaseRanking":91},{"id":75,"createTime":18,"updateTime":18,"relativeEntities":773,"label":774,"description":775,"key":81,"publicationTags":776,"standard":18},[],{"EN":78,"VI":78},{"EN":78,"VI":80},[83],[87,88,89,90],{"pages":779,"volume":781},{"VOID":780},"199-203",{"VOID":782},"66",{"total":19,"publishYear":784,"statisticByYear":785},2022,{},"2022-12-01","2026-07-23T07:34:02.899+00:00",[66,91],{"id":790,"createTime":791,"updateTime":792,"relativeEntities":793,"slug":794,"properties":795,"entityType":109,"verifyStatus":110,"verifyTime":791,"verifyNote":112,"languages":810,"translateLanguages":18,"viewCount":19,"primaryUrl":812,"fullTextUrl":18,"authors":813,"publicationType":265,"publisherRelationship":964,"citationCount":1013,"citationInfo":1014,"publishDate":1017,"publishYear":1015,"citationAnalyzeStatus":1018,"lastCitationAnalyze":1019,"indexDatabases":1020,"openAccess":18,"references":1021,"isForceReanalyzing":399},"9ace7560-1e15-4cec-815c-7b5272eb7b73","2024-12-03T05:27:12.784+00:00","2026-07-22T17:53:33.789+00:00",[],"Mammographic-sensitivity-as-a-function-of-tumor-size-A-novel-estimation-based-on-population-based-screening-data",{"mag":796,"gsPaper":798,"pmc":800,"openalex":802,"title":804,"pm":806,"doi":808},{"VOID":797},"3111372510",{"VOID":799},"[]",{"VOID":801},"7753195",{"VOID":803},"W3111372510",{"EN":805},"Mammographic sensitivity as a function of tumor size: A novel estimation based on population-based screening data",{"VOID":807},"33348148",{"VOID":809},"10.1016\u002Fj.breast.2020.12.003",[811],"EN","https:\u002F\u002Flinkinghub.elsevier.com\u002Fretrieve\u002Fpii\u002FS0960977620302320",[814,833,848,865,882,901,920,947],{"id":815,"sortIndex":19,"researcher":18,"roles":816,"affiliations":817,"properties":826,"displayName":830,"givenName":18,"familyName":18},"bf107919-05e6-4391-9941-c849404d1be5",[],[818],{"id":819,"sortIndex":19,"affiliation":820,"properties":18},"74172100-a9a8-4363-953d-5bde09185f1c",{"id":819,"createTime":18,"updateTime":18,"relativeEntities":821,"slug":18,"properties":822,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":825,"statistic":18},[],{"title":823},{"VI":824},"University of Groningen, University Medical Center Groningen, Department of Epidemiology, Groningen, the Netherlands",[],{"orcid":827,"title":829,"openalex":831},{"VOID":828},"https:\u002F\u002Forcid.org\u002F0000-0001-8634-7942",{"EN":830},"Jing Wang",{"VOID":832},"A5100378389",{"id":834,"sortIndex":135,"researcher":18,"roles":835,"affiliations":836,"properties":843,"displayName":845,"givenName":18,"familyName":18},"5fec5d14-e66b-4bb2-b2ba-0bcc23f00461",[],[837],{"id":819,"sortIndex":19,"affiliation":838,"properties":18},{"id":819,"createTime":18,"updateTime":18,"relativeEntities":839,"slug":18,"properties":840,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":842,"statistic":18},[],{"title":841},{"VI":824},[],{"title":844,"openalex":846},{"EN":845},"Pam Gottschal",{"VOID":847},"A5031640538",{"id":849,"sortIndex":151,"researcher":18,"roles":850,"affiliations":851,"properties":858,"displayName":862,"givenName":18,"familyName":18},"942a1177-8462-467d-9275-33ce32a0bd0e",[],[852],{"id":819,"sortIndex":19,"affiliation":853,"properties":18},{"id":819,"createTime":18,"updateTime":18,"relativeEntities":854,"slug":18,"properties":855,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":857,"statistic":18},[],{"title":856},{"VI":824},[],{"orcid":859,"title":861,"openalex":863},{"VOID":860},"https:\u002F\u002Forcid.org\u002F0000-0003-1748-4104",{"EN":862},"Lilu Ding",{"VOID":864},"A5014657594",{"id":866,"sortIndex":167,"researcher":18,"roles":867,"affiliations":868,"properties":875,"displayName":879,"givenName":18,"familyName":18},"8310b0d3-83da-42ff-8bd6-9a4205c3954a",[],[869],{"id":819,"sortIndex":19,"affiliation":870,"properties":18},{"id":819,"createTime":18,"updateTime":18,"relativeEntities":871,"slug":18,"properties":872,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":874,"statistic":18},[],{"title":873},{"VI":824},[],{"orcid":876,"title":878,"openalex":880},{"VOID":877},"https:\u002F\u002Forcid.org\u002F0000-0002-7295-9005",{"EN":879},"Willemina A. van Veldhuizen",{"VOID":881},"A5052460106",{"id":883,"sortIndex":183,"researcher":18,"roles":884,"affiliations":885,"properties":894,"displayName":898,"givenName":18,"familyName":18},"e46b9639-ace6-4a19-acc2-e4549155297a",[],[886],{"id":887,"sortIndex":19,"affiliation":888,"properties":18},"6d1865ff-9f66-4114-93ff-9e011d2291d6",{"id":887,"createTime":18,"updateTime":18,"relativeEntities":889,"slug":18,"properties":890,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":893,"statistic":18},[],{"title":891},{"VI":892},"Department of Epidemiology and Health Statistics, School of Public Health, Tianjin Medical University, Tianjin, China",[],{"orcid":895,"title":897,"openalex":899},{"VOID":896},"https:\u002F\u002Forcid.org\u002F0000-0003-2894-7506",{"EN":898},"Wenli Lu",{"VOID":900},"A5102972572",{"id":902,"sortIndex":197,"researcher":18,"roles":903,"affiliations":904,"properties":913,"displayName":917,"givenName":18,"familyName":18},"dec25664-4125-46a7-b4f7-855d6d373a60",[],[905],{"id":906,"sortIndex":19,"affiliation":907,"properties":18},"b62b6055-1084-4463-b4eb-4b71f3061f15",{"id":906,"createTime":18,"updateTime":18,"relativeEntities":908,"slug":18,"properties":909,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":912,"statistic":18},[],{"title":910},{"VI":911},"Sydney School of Public Health, Faculty of Medicine and Health, University of Sydney, Australia",[],{"orcid":914,"title":916,"openalex":918},{"VOID":915},"https:\u002F\u002Forcid.org\u002F0000-0002-3641-952X",{"EN":917},"Nehmat Houssami",{"VOID":919},"A5003268089",{"id":921,"sortIndex":211,"researcher":18,"roles":922,"affiliations":923,"properties":940,"displayName":944,"givenName":18,"familyName":18},"5842838e-a82e-4db6-b478-7f1674078634",[],[924,932],{"id":925,"sortIndex":19,"affiliation":926,"properties":18},"5d5619af-9c1a-4d82-9faa-c5576af1b54f",{"id":925,"createTime":18,"updateTime":18,"relativeEntities":927,"slug":18,"properties":928,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":931,"statistic":18},[],{"title":929},{"VI":930},"Robotics and Mechatronics (RaM) Group, Faculty of Electrical Engineering Mathematics and Computer Science, Technical Medical Centre, University of Twente, Enschede, The Netherlands",[],{"id":933,"sortIndex":135,"affiliation":934,"properties":18},"9dcbe9f6-c621-4f6a-a0cb-178d0f8399e4",{"id":933,"createTime":18,"updateTime":18,"relativeEntities":935,"slug":18,"properties":936,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":939,"statistic":18},[],{"title":937},{"VI":938},"University of Groningen, University Medical Center Groningen, Department of Radiology, Groningen, The Netherlands",[],{"orcid":941,"title":943,"openalex":945},{"VOID":942},"https:\u002F\u002Forcid.org\u002F0000-0001-5721-9159",{"EN":944},"Marcel J. W. Greuter",{"VOID":946},"A5022759190",{"id":948,"sortIndex":225,"researcher":18,"roles":949,"affiliations":950,"properties":957,"displayName":961,"givenName":18,"familyName":18},"89a0448e-c507-4ad4-9670-a2c8a20cc3f7",[],[951],{"id":819,"sortIndex":19,"affiliation":952,"properties":18},{"id":819,"createTime":18,"updateTime":18,"relativeEntities":953,"slug":18,"properties":954,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":956,"statistic":18},[],{"title":955},{"VI":824},[],{"orcid":958,"title":960,"openalex":962},{"VOID":959},"https:\u002F\u002Forcid.org\u002F0000-0003-3104-4471",{"EN":961},"Geertruida H. de Bock",{"VOID":963},"A5070838971",{"url":18,"publisher":965,"properties":1008},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":966,"slug":10,"properties":967,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":970,"manageAffiliations":987,"indexDatabases":993,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":968,"title":969},{"VOID":13},{"EN":15},[971,975,979,983],{"id":22,"createTime":18,"updateTime":18,"relativeEntities":972,"label":973,"description":974,"parentId":18,"standard":18,"scholarHubFieldId":18},[],{"EN":25},{},{"id":28,"createTime":18,"updateTime":18,"relativeEntities":976,"label":977,"description":978,"parentId":18,"standard":18,"scholarHubFieldId":18},[],{"EN":31},{},{"id":34,"createTime":18,"updateTime":18,"relativeEntities":980,"label":981,"description":982,"parentId":18,"standard":18,"scholarHubFieldId":18},[],{"EN":37},{},{"id":40,"createTime":18,"updateTime":18,"relativeEntities":984,"label":985,"description":986,"parentId":18,"standard":18,"scholarHubFieldId":18},[],{"EN":43},{},[988],{"id":47,"createTime":18,"updateTime":18,"relativeEntities":989,"slug":18,"properties":990,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":992,"statistic":18},[],{"title":991},{"EN":51},[],[994,1001],{"id":55,"indexDatabase":995,"url":68,"indexYears":18,"academicFieldIds":1000,"indexDatabaseRanking":18},{"id":57,"createTime":18,"updateTime":18,"relativeEntities":996,"label":997,"description":998,"key":64,"publicationTags":999,"standard":18},[],{"EN":60,"VI":60},{"EN":62,"VI":63},[66,67],[70,71],{"id":73,"indexDatabase":1002,"url":84,"indexYears":85,"academicFieldIds":1007,"indexDatabaseRanking":91},{"id":75,"createTime":18,"updateTime":18,"relativeEntities":1003,"label":1004,"description":1005,"key":81,"publicationTags":1006,"standard":18},[],{"EN":78,"VI":78},{"EN":78,"VI":80},[83],[87,88,89,90],{"pages":1009,"volume":1011},{"VOID":1010},"69-74",{"VOID":1012},"55",16,{"total":1013,"publishYear":1015,"statisticByYear":1016},2021,{"2021":135,"2022":167,"2023":211,"2024":211},"2021-02-01","ERROR_IN_GET_PLATFORM_ID","2026-07-22T17:53:33.788+00:00",[66,91],[1022,1026,1030,1033,1037,1041,1045,1049,1053,1057,1061,1065,1069,1073,1076,1080,1084,1088,1092,1095,1099,1103,1107,1111,1115,1119,1123,1127,1131,1135,1139,1143,1147,1151,1155,1159,1163,1167,1171,1175,1179,1183,1187,1191],{"id":18,"text":1023,"url":18,"identifiers":1024},"van Der Waal, 2015, Breast cancer diagnosis and death in The Netherlands: a changing burden, Eur J Publ Health, 25, 320, 10.1093\u002Feurpub\u002Fcku088",{"doi":1025},"10.1093\u002Feurpub\u002Fcku088",{"id":18,"text":1027,"url":18,"identifiers":1028},"Altobelli, 2017, Breast cancer screening programmes across the WHO European region: differences among countries based on national income level, Int J Environ Res Publ Health, 14, 452, 10.3390\u002Fijerph14040452",{"doi":1029},"10.3390\u002Fijerph14040452",{"id":18,"text":1031,"url":18,"identifiers":1032},"Shaevitch, 2017, Tumor size distribution of invasive breast cancers and the sensitivity of screening methods in the Canadian National Breast Screening Study, J Canc Res Therapeut, 13, 562",{},{"id":18,"text":1034,"url":18,"identifiers":1035},"de Munck, 2018, Is the incidence of advanced-stage breast cancer affected by whether women attend a steady-state screening program?, Int J Canc, 143, 842, 10.1002\u002Fijc.31388",{"doi":1036},"10.1002\u002Fijc.31388",{"id":18,"text":1038,"url":18,"identifiers":1039},"Mandrik, 2019, Systematic reviews as a ‘lens of evidence’: determinants of benefits and harms of breast cancer screening, Int J Canc, 145, 994, 10.1002\u002Fijc.32211",{"doi":1040},"10.1002\u002Fijc.32211",{"id":18,"text":1042,"url":18,"identifiers":1043},"Abrahamsson, 2016, A statistical model of breast cancer tumour growth with estimation of screening sensitivity as a function of mammographic density, Stat Methods Med Res, 25, 1620, 10.1177\u002F0962280213492843",{"doi":1044},"10.1177\u002F0962280213492843",{"id":18,"text":1046,"url":18,"identifiers":1047},"1994, Quality standards compliance for mammography facilities, J Am Med Assoc, 272, 763, 10.1001\u002Fjama.1994.03520100027011",{"doi":1048},"10.1001\u002Fjama.1994.03520100027011",{"id":18,"text":1050,"url":18,"identifiers":1051},"Hakama, 2007, Sensitivity in cancer screening, J Med Screen, 14, 174, 10.1258\u002F096914107782912077",{"doi":1052},"10.1258\u002F096914107782912077",{"id":18,"text":1054,"url":18,"identifiers":1055},"Herman, 2002, Screening for preclinical disease: test and disease characteristics, AJR Am J Roentgenol, 179, 825, 10.2214\u002Fajr.179.4.1790825",{"doi":1056},"10.2214\u002Fajr.179.4.1790825",{"id":18,"text":1058,"url":18,"identifiers":1059},"Weedon-Fekjær, 2008, Breast cancer tumor growth estimated through mammography screening data, Breast Cancer Res, 10, R41, 10.1186\u002Fbcr2092",{"doi":1060},"10.1186\u002Fbcr2092",{"id":18,"text":1062,"url":18,"identifiers":1063},"Weedon-Fekjær, 2010, Estimating screening test sensitivity and tumour progression using tumour size and time since previous screening, Stat Methods Med Res, 19, 507, 10.1177\u002F0962280209359860",{"doi":1064},"10.1177\u002F0962280209359860",{"id":18,"text":1066,"url":18,"identifiers":1067},"Isheden, 2019, Modelling breast cancer tumour growth for a stable disease population, Stat Methods Med Res, 28, 681, 10.1177\u002F0962280217734583",{"doi":1068},"10.1177\u002F0962280217734583",{"id":18,"text":1070,"url":18,"identifiers":1071},"Abrahamsson, 2020, Continuous tumour growth models, lead time estimation and length bias in breast cancer screening studies, Stat Methods Med Res, 29, 374, 10.1177\u002F0962280219832901",{"doi":1072},"10.1177\u002F0962280219832901",{"id":18,"text":1074,"url":18,"identifiers":1075},"Fracheboud, 2014",{},{"id":18,"text":1077,"url":18,"identifiers":1078},"Simbrich, 2016, Trends in advanced breast cancer incidence rates after implementation of a mammography screening program in a German population, Cancer Epidemiol, 44, 44, 10.1016\u002Fj.canep.2016.07.006",{"doi":1079},"10.1016\u002Fj.canep.2016.07.006",{"id":18,"text":1081,"url":18,"identifiers":1082},"Hofvind, 2007, Using the European guidelines to evaluate the Norwegian breast cancer screening program, Eur J Epidemiol, 22, 447, 10.1007\u002Fs10654-007-9137-y",{"doi":1083},"10.1007\u002Fs10654-007-9137-y",{"id":18,"text":1085,"url":18,"identifiers":1086},"Rajentheran, 2001, Palpable breast cancer which is mammographically invisible, Breast, 10, 416, 10.1054\u002Fbrst.2000.0270",{"doi":1087},"10.1054\u002Fbrst.2000.0270",{"id":18,"text":1089,"url":18,"identifiers":1090},"Foxcroft, 2000, Breast cancers invisible on mammography, Aust N Z J Surg, 70, 162, 10.1046\u002Fj.1440-1622.2000.01763.x",{"doi":1091},"10.1046\u002Fj.1440-1622.2000.01763.x",{"id":18,"text":1093,"url":18,"identifiers":1094},"Collins, 1956, Observations on growth rates of human tumors, Am J Roentgenol, 76, 988",{},{"id":18,"text":1096,"url":18,"identifiers":1097},"Peer, 1993, Age-dependent growth rate of primary breast cancer, Cancer, 71, 3547, 10.1002\u002F1097-0142(19930601)71:11\u003C3547::AID-CNCR2820711114>3.0.CO;2-C",{"doi":1098},"10.1002\u002F1097-0142(19930601)71:11\u003C3547::AID-CNCR2820711114>3.0.CO;2-C",{"id":18,"text":1100,"url":18,"identifiers":1101},"Hofvind, 2008, Incidence and tumor characteristics of breast cancer diagnosed before and after implementation of a population-based screening-program, Acta Oncol, 47, 225, 10.1080\u002F02841860701518041",{"doi":1102},"10.1080\u002F02841860701518041",{"id":18,"text":1104,"url":18,"identifiers":1105},"Ciatto, 2007, Minority report–false negative breast assessment in women recalled for suspicious screening mammography: imaging and pathological features, and associated delay in diagnosis, Breast Canc Res Treat, 105, 37, 10.1007\u002Fs10549-006-9425-3",{"doi":1106},"10.1007\u002Fs10549-006-9425-3",{"id":18,"text":1108,"url":18,"identifiers":1109},"Wang, 2001, Interval cancers in the Norwegian breast cancer screening program: frequency, characteristics and use of HRT, Int J Canc, 94, 594, 10.1002\u002Fijc.1511",{"doi":1110},"10.1002\u002Fijc.1511",{"id":18,"text":1112,"url":18,"identifiers":1113},"Cawson, 2009, Invasive breast cancers detected by screening mammography: a detailed comparison of computer-aided detection-assisted single reading and double reading, J Med Imaging Radiat Oncol, 53, 442, 10.1111\u002Fj.1754-9485.2009.02100.x",{"doi":1114},"10.1111\u002Fj.1754-9485.2009.02100.x",{"id":18,"text":1116,"url":18,"identifiers":1117},"Moshina, 2018, Automated volumetric analysis of mammographic density in a screening setting: worse outcomes for women with dense breasts, Radiology, 288, 343, 10.1148\u002Fradiol.2018172972",{"doi":1118},"10.1148\u002Fradiol.2018172972",{"id":18,"text":1120,"url":18,"identifiers":1121},"Skaane, 2018, Performance of breast cancer screening using digital breast tomosynthesis: results from the prospective population-based Oslo Tomosynthesis Screening Trial, Breast Canc Res Treat, 169, 489, 10.1007\u002Fs10549-018-4705-2",{"doi":1122},"10.1007\u002Fs10549-018-4705-2",{"id":18,"text":1124,"url":18,"identifiers":1125},"Lameijer, 2020, Delayed breast cancer diagnosis after repeated recall at biennial screening mammography: an observational follow-up study from The Netherlands, Br J Canc, 123, 325, 10.1038\u002Fs41416-020-0870-2",{"doi":1126},"10.1038\u002Fs41416-020-0870-2",{"id":18,"text":1128,"url":18,"identifiers":1129},"Domingo, 2016, Cross-national comparison of screening mammography accuracy measures in US, Norway, and Spain, Eur Radiol, 26, 2520, 10.1007\u002Fs00330-015-4074-8",{"doi":1130},"10.1007\u002Fs00330-015-4074-8",{"id":18,"text":1132,"url":18,"identifiers":1133},"Baines, 1999, A tangled web: factors likely to affect the efficacy of screening mammography, J Natl Cancer Inst, 91, 833, 10.1093\u002Fjnci\u002F91.10.833",{"doi":1134},"10.1093\u002Fjnci\u002F91.10.833",{"id":18,"text":1136,"url":18,"identifiers":1137},"Ma, 1992, Case-control study of factors associated with failure to detect breast cancer by mammography, J Natl Cancer Inst, 84, 781, 10.1093\u002Fjnci\u002F84.10.781",{"doi":1138},"10.1093\u002Fjnci\u002F84.10.781",{"id":18,"text":1140,"url":18,"identifiers":1141},"Wadhwa, 2016, Missed breast cancer: what can we learn?, Curr Probl Diagn Radiol, 45, 402, 10.1067\u002Fj.cpradiol.2016.03.001",{"doi":1142},"10.1067\u002Fj.cpradiol.2016.03.001",{"id":18,"text":1144,"url":18,"identifiers":1145},"Huynh, 1998, The false-negative mammogram, Radiographics, 18, 1137, 10.1148\u002Fradiographics.18.5.9747612",{"doi":1146},"10.1148\u002Fradiographics.18.5.9747612",{"id":18,"text":1148,"url":18,"identifiers":1149},"Spratt, 1993, Decelerating growth and human breast cancer, Cancer, 71, 2013, 10.1002\u002F1097-0142(19930315)71:6\u003C2013::AID-CNCR2820710615>3.0.CO;2-V",{"doi":1150},"10.1002\u002F1097-0142(19930315)71:6\u003C2013::AID-CNCR2820710615>3.0.CO;2-V",{"id":18,"text":1152,"url":18,"identifiers":1153},"Spratt, 1993, Mammographic assessment of human breast cancer growth and duration, Cancer, 71, 2020, 10.1002\u002F1097-0142(19930315)71:6\u003C2020::AID-CNCR2820710616>3.0.CO;2-#",{"doi":1154},"10.1002\u002F1097-0142(19930315)71:6\u003C2020::AID-CNCR2820710616>3.0.CO;2-#",{"id":18,"text":1156,"url":18,"identifiers":1157},"Plevritis, 2007, A natural history model of stage progression applied to breast cancer, Stat Med, 26, 581, 10.1002\u002Fsim.2550",{"doi":1158},"10.1002\u002Fsim.2550",{"id":18,"text":1160,"url":18,"identifiers":1161},"Talkington, 2015, Estimating tumor growth rates in vivo, Bull Math Biol, 77, 1934, 10.1007\u002Fs11538-015-0110-8",{"doi":1162},"10.1007\u002Fs11538-015-0110-8",{"id":18,"text":1164,"url":18,"identifiers":1165},"Sarapata, 2014, A comparison and catalog of intrinsic tumor growth models, Bull Math Biol, 76, 2010, 10.1007\u002Fs11538-014-9986-y",{"doi":1166},"10.1007\u002Fs11538-014-9986-y",{"id":18,"text":1168,"url":18,"identifiers":1169},"Weedon-Fekjær, 2005, Estimating mean sojourn time and screening test sensitivity in breast cancer mammography screening: new results, J Med Screen, 12, 172, 10.1258\u002F096914105775220732",{"doi":1170},"10.1258\u002F096914105775220732",{"id":18,"text":1172,"url":18,"identifiers":1173},"De Gelder, 2011, Digital mammography screening: weighing reduced mortality against increased overdiagnosis, Prev Med, 53, 134, 10.1016\u002Fj.ypmed.2011.06.009",{"doi":1174},"10.1016\u002Fj.ypmed.2011.06.009",{"id":18,"text":1176,"url":18,"identifiers":1177},"Rijnsburger, 2004, Mammography benefit in the Canadian national breast screening study-2: a model evaluation, Int J Canc, 110, 756, 10.1002\u002Fijc.20143",{"doi":1178},"10.1002\u002Fijc.20143",{"id":18,"text":1180,"url":18,"identifiers":1181},"Tabar, 1995, Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial, Cancer, 75, 2507, 10.1002\u002F1097-0142(19950515)75:10\u003C2507::AID-CNCR2820751017>3.0.CO;2-H",{"doi":1182},"10.1002\u002F1097-0142(19950515)75:10\u003C2507::AID-CNCR2820751017>3.0.CO;2-H",{"id":18,"text":1184,"url":18,"identifiers":1185},"Zahl, 2008, The natural history of invasive breast cancers detected by screening mammography, Arch Intern Med, 168, 2311, 10.1001\u002Farchinte.168.21.2311",{"doi":1186},"10.1001\u002Farchinte.168.21.2311",{"id":18,"text":1188,"url":18,"identifiers":1189},"Brekelmans, 1996, Histopathology and growth rate of interval breast carcinoma: characterization of different subgroups, Cancer, 78, 1220, 10.1002\u002F(SICI)1097-0142(19960915)78:6\u003C1220::AID-CNCR8>3.0.CO;2-D",{"doi":1190},"10.1002\u002F(SICI)1097-0142(19960915)78:6\u003C1220::AID-CNCR8>3.0.CO;2-D",{"id":18,"text":1192,"url":18,"identifiers":1193},"Carney, 2003, Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography, Ann Intern Med, 138, 168, 10.7326\u002F0003-4819-138-3-200302040-00008",{"doi":1194},"10.7326\u002F0003-4819-138-3-200302040-00008",{"id":1196,"createTime":1197,"updateTime":1198,"relativeEntities":1199,"slug":1200,"properties":1201,"entityType":109,"verifyStatus":110,"verifyTime":1210,"verifyNote":112,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":1211,"fullTextUrl":18,"authors":1212,"publicationType":265,"publisherRelationship":1279,"citationCount":253,"citationInfo":1328,"publishDate":1331,"publishYear":1329,"citationAnalyzeStatus":320,"lastCitationAnalyze":1332,"indexDatabases":1333,"openAccess":18,"references":18,"isForceReanalyzing":399},"c3f88c25-51c1-4ebd-8160-68839eb41985","2024-01-10T07:41:31.853+00:00","2026-07-20T08:01:45.688+00:00",[],"Delayed-presentation-in-breast-cancer-relationship-to-tumour-stage-and-survival",{"title":1202,"gsPaper":1204,"references":1206,"doi":1208},{"EN":1203},"Delayed presentation in breast cancer: relationship to tumour stage and survival",{"VOID":1205},"[\"2339567397590016746\"]",{"VOID":1207},"Shapiro, 1982, Ten-to fourteen-year effect of breast cancer screening on mortality, JNCI, 69, 349\nTabar, 1985, Reduction in mortality from breast cancer after mass screening with mammography, Lancet, i, 829, 10.1016\u002FS0140-6736(85)92204-4\nFrisell, 1989, The Stockholm breast cancer screening trial - 5-year results and stage at discovery, Breast Cancer Res Treat, 13, 79, 10.1007\u002FBF01806553\nBloom, 1962, Natural history of untreated breast cancer (1805–1933): comparison of untreated and treated cases according to histological grade of malignancy, BMJ, 2, 213, 10.1136\u002Fbmj.2.5299.213\nPark, 1951, The absolute curability of cancer of the breast, Surg Gynecol Obstet, 93, 129\nBloom, 1965, The influence of delay on the natural history and prognosis of breast cancer, B J Cancer, 19, 228, 10.1038\u002Fbjc.1965.28\nDennis, 1975, Analysis of survival and recurrence vs. patient and doctor delay in treatment of breast cancer, Cancer, 35, 714, 10.1002\u002F1097-0142(197503)35:3\u003C714::AID-CNCR2820350326>3.0.CO;2-V\nFisher, 1977, A perspective concerning the relation of duration of symptoms to treatment failure in patients with breast cancer, Cancer, 40, 3160, 10.1002\u002F1097-0142(197712)40:6\u003C3160::AID-CNCR2820400661>3.0.CO;2-P\nLewis, 1931, A study of the results of operations for the cure of cancer of the breast, Ann Surg, 95, 336, 10.1097\u002F00000658-193203000-00003\nBerkson, 1962, Prognosis of malignant of malignant tumors of the breast: a review of recent experience of the Mayo Clinic, Acta Unio Internationalis Contra Cancrum, 18, 1003\nTreves, 1958, A report of 549 cases of breast cancer in women 35 years of age or younger, Surg Gynecol Obstet, 107, 271\nMcWhirter, 1957, Some factors influencing prognosis in breast cancer, J Fac Radiol, 8, 220, 10.1016\u002FS0368-2242(57)80020-7\nSheridan, 1971, The effects of delay in treatment on survival rates in carcinoma of the breast, Med J Aust, 1, 262, 10.5694\u002Fj.1326-5377.1971.tb87551.x\nElwood, 1980, Delay in diagnosis and long-term survival in breast cancer, 280, 1291\nUICC, 1987, International Union against Cancer\nMercer, 1983, Hormone-receptor assays in breast cancer: a five-year experience, Med J Aust, 1, 365, 10.5694\u002Fj.1326-5377.1983.tb99413.x\nKaplan, 1958, Nonparametric estimation from incomplete observation, J Am Stat Assoc, 53, 457, 10.1080\u002F01621459.1958.10501452\nPeto, 1973, Conservatism of the approximation Σ(O-E)2E in the logrank test for survival data or tumor incidence data, Biometrics, 29, 579, 10.2307\u002F2529177\nAitken-Swan, 1955, The cancer patient: delay in seeking advice, BMJ, 1, 623, 10.1136\u002Fbmj.1.4914.623\nWatson, 1984, Reaction to a diagnosis of breast cancer, Cancer, 53, 2008, 10.1002\u002F1097-0142(19840501)53:9\u003C2008::AID-CNCR2820530934>3.0.CO;2-B\n1981, Lancet, ii, 785\nHinton, 1984, Results of a programme of education and breast self examination, 10",{"VOID":1209},"10.1016\u002F0960-9776(93)90035-e","2024-06-26T08:26:13.643+00:00","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002F096097769390035E",[1213,1237,1259],{"id":1214,"sortIndex":19,"researcher":18,"roles":1215,"affiliations":1216,"properties":1234,"displayName":1236,"givenName":18,"familyName":18},"bd926d66-6d88-4522-88eb-1a3db8aa6628",[118],[1217,1225],{"id":1218,"sortIndex":19,"affiliation":1219,"properties":18},"842725e0-1ed9-43ae-b762-70a3e02f4941",{"id":1218,"createTime":18,"updateTime":18,"relativeEntities":1220,"slug":18,"properties":1221,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":1224,"statistic":18},[],{"title":1222},{"VI":1223},"Royal Victoria Infirmary, Newcastle-upon-Tyne, UK",[],{"id":1226,"sortIndex":135,"affiliation":1227,"properties":1233},"be30f99a-a7e7-4499-84d7-30e934bb302d",{"id":1226,"createTime":18,"updateTime":18,"relativeEntities":1228,"slug":18,"properties":1229,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":1232,"statistic":18},[],{"title":1230},{"VI":1231},"Department of Surgery, Newcastle-upon-Tyne, UK",[],{},{"title":1235},{"VI":1236},"P.J Hainsworth",{"id":1238,"sortIndex":135,"researcher":18,"roles":1239,"affiliations":1240,"properties":1256,"displayName":1258,"givenName":18,"familyName":18},"b415388a-75cd-4c48-b8da-8f5b29a03a17",[118],[1241,1249],{"id":1242,"sortIndex":19,"affiliation":1243,"properties":18},"b3aa68fb-46e6-47bd-8b28-e1a88ff20c27",{"id":1242,"createTime":18,"updateTime":18,"relativeEntities":1244,"slug":18,"properties":1245,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":1248,"statistic":18},[],{"title":1246},{"VI":1247},"St Vincent’s Hospital, Melbourne, Australia",[],{"id":1226,"sortIndex":135,"affiliation":1250,"properties":1255},{"id":1226,"createTime":18,"updateTime":18,"relativeEntities":1251,"slug":18,"properties":1252,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":1254,"statistic":18},[],{"title":1253},{"VI":1231},[],{},{"title":1257},{"VI":1258},"M.A Henderson",{"id":1260,"sortIndex":151,"researcher":18,"roles":1261,"affiliations":1262,"properties":1276,"displayName":1278,"givenName":18,"familyName":18},"325025b7-793a-4513-960c-39bc03834974",[118],[1263,1269],{"id":1242,"sortIndex":19,"affiliation":1264,"properties":18},{"id":1242,"createTime":18,"updateTime":18,"relativeEntities":1265,"slug":18,"properties":1266,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":1268,"statistic":18},[],{"title":1267},{"VI":1247},[],{"id":1226,"sortIndex":135,"affiliation":1270,"properties":1275},{"id":1226,"createTime":18,"updateTime":18,"relativeEntities":1271,"slug":18,"properties":1272,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":1274,"statistic":18},[],{"title":1273},{"VI":1231},[],{},{"title":1277},{"VI":1278},"R.C Bennett",{"url":1211,"publisher":1280,"properties":1323},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":1281,"slug":10,"properties":1282,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":1285,"manageAffiliations":1302,"indexDatabases":1308,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":1283,"title":1284},{"VOID":13},{"EN":15},[1286,1290,1294,1298],{"id":22,"createTime":18,"updateTime":18,"relativeEntities":1287,"label":1288,"description":1289,"parentId":18,"standard":18,"scholarHubFieldId":18},[],{"EN":25},{},{"id":28,"createTime":18,"updateTime":18,"relativeEntities":1291,"label":1292,"description":1293,"parentId":18,"standard":18,"scholarHubFieldId":18},[],{"EN":31},{},{"id":34,"createTime":18,"updateTime":18,"relativeEntities":1295,"label":1296,"description":1297,"parentId":18,"standard":18,"scholarHubFieldId":18},[],{"EN":37},{},{"id":40,"createTime":18,"updateTime":18,"relativeEntities":1299,"label":1300,"description":1301,"parentId":18,"standard":18,"scholarHubFieldId":18},[],{"EN":43},{},[1303],{"id":47,"createTime":18,"updateTime":18,"relativeEntities":1304,"slug":18,"properties":1305,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":1307,"statistic":18},[],{"title":1306},{"EN":51},[],[1309,1316],{"id":55,"indexDatabase":1310,"url":68,"indexYears":18,"academicFieldIds":1315,"indexDatabaseRanking":18},{"id":57,"createTime":18,"updateTime":18,"relativeEntities":1311,"label":1312,"description":1313,"key":64,"publicationTags":1314,"standard":18},[],{"EN":60,"VI":60},{"EN":62,"VI":63},[66,67],[70,71],{"id":73,"indexDatabase":1317,"url":84,"indexYears":85,"academicFieldIds":1322,"indexDatabaseRanking":91},{"id":75,"createTime":18,"updateTime":18,"relativeEntities":1318,"label":1319,"description":1320,"key":81,"publicationTags":1321,"standard":18},[],{"EN":78,"VI":78},{"EN":78,"VI":80},[83],[87,88,89,90],{"pages":1324,"volume":1326},{"VOID":1325},"37-41",{"VOID":1327},"2",{"total":253,"publishYear":1329,"statisticByYear":1330},1993,{"1908":135,"1995":135,"1999":151,"2003":151,"2004":151,"2017":135},"1993-03-01","2026-07-20T08:01:45.687+00:00",[66,91],{"id":1335,"createTime":1336,"updateTime":1337,"relativeEntities":1338,"slug":1339,"properties":1340,"entityType":109,"verifyStatus":110,"verifyTime":1349,"verifyNote":112,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":1350,"fullTextUrl":18,"authors":1351,"publicationType":265,"publisherRelationship":1683,"citationCount":167,"citationInfo":1732,"publishDate":1735,"publishYear":1733,"citationAnalyzeStatus":17,"lastCitationAnalyze":1736,"indexDatabases":1737,"openAccess":18,"references":18,"isForceReanalyzing":399},"304a21e5-2f27-49d4-80f2-ff13f7a16545","2024-01-20T02:02:19.513+00:00","2026-07-17T15:48:54.903+00:00",[],"The-impact-of-organized-breast-assessment-on-survival-by-stage-for-screened-women-diagnosed-with-invasive-breast-cancer",{"title":1341,"gsPaper":1343,"references":1345,"doi":1347},{"EN":1342},"The impact of organized breast assessment on survival by stage for screened women diagnosed with invasive breast cancer",{"VOID":1344},"[\"2218592382287292126\"]",{"VOID":1346},"The Workshop Group, 1989, Reducing deaths from breast cancer in Canada, Can Med Assoc J, 141, 199\nRimer, 1997, The psychosocial consequences of mammography, J Natl Cancer Inst Monogr, 22, 131, 10.1093\u002Fjncimono\u002F1997.22.131\nBrett, 1998, Do women who undergo further investigation for breast screening suffer adverse psychological consequences? A multi-centre follow-up study comparing different breast screening result groups five months after their last breast screening appointment, J Publ Health Med, 20, 396, 10.1093\u002Foxfordjournals.pubmed.a024793\nSutton, 1995, Does routine screening for breast cancer raise anxiety? Results from a three wave prospective study in England, J Epidemiol Community Health, 49, 413, 10.1136\u002Fjech.49.4.413\nGanry, 2004, Influence of abnormal screens on delays and prognostic indicators of screen-detected breast carcinoma, J Med Screen, 11, 28, 10.1177\u002F096914130301100107\nOlivotto, 2002, Influence of delay to diagnosis on prognostic indicators of screen-detected breast carcinoma, Cancer, 94, 2143, 10.1002\u002Fcncr.10453\nCancer Care Ontario, 2016\nKalager, 2009, Improved breast cancer survival following introduction of an organized mammography screening program among both screened and unscreened women: a population-based cohort study, Breast Cancer Res, 11, R44, 10.1186\u002Fbcr2331\nBeckmann, 2011, Quality assured health care in certified breast centers and improvement of the prognosis of breast cancer patients, Onkologie, 34, 362, 10.1159\u002F000329601\nSchrodi, 2015, No survival benefit for patients with treatment in certified breast centers—a population-based evaluation of German cancer registry data, Breast J, 21, 490, 10.1111\u002Ftbj.12444\nObi, 2011, Impact of the Quality assured Mamma Diagnostic (QuaMaDi) programme on survival of breast cancer patients, Canc Epidemiol, 35, 286, 10.1016\u002Fj.canep.2010.09.001\nOntario Breast Screening Program, 2001\nChiarelli, 2017, Evaluating wait times from screening to breast cancer diagnosis among women undergoing organised assessment vs usual care, Br J Canc, 116, 1254, 10.1038\u002Fbjc.2017.87\nChiarelli, 2013, Digital compared with screen-film mammography: performance measures in concurrent cohorts within an organized breast screening program, Radiology, 268, 684, 10.1148\u002Fradiol.13122567\nQuan, 2012, Improving work-up of the abnormal mammogram through organized assessment: results from the ontario breast screening program, J Oncol Pract, 8, 107, 10.1200\u002FJOP.2011.000413\nJaro, 1995, Probabilistic linkage of large public health data files, Stat Med, 14, 491, 10.1002\u002Fsim.4780140510\nStatistics Canada, 2014\nCharlson, 1987, A new method of classifying prognostic comorbidity in longitudinal studies: development and validation, J Chron Dis, 40, 373, 10.1016\u002F0021-9681(87)90171-8\nCanadian Breast Cancer Screening Initiative Working Group, 2000\nCanadian Partnership Against Cancer, 2013\nAmerican Joint Committee on Cancer, 2002\nHammond, 2010, American Society of Clinical Oncology\u002FCollege of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version), Arch Pathol Lab Med, 134, 10.5858\u002F134.6.907\nWolff, 2007, American society of clinical oncology\u002Fcollege of American pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer, Arch Pathol Lab Med, 131, 18, 10.5858\u002F2007-131-18-ASOCCO\nLouwman, 2005, Less extensive treatment and inferior prognosis for breast cancer patient with comorbidity: a population-based study, Eur J Canc, 41, 779, 10.1016\u002Fj.ejca.2004.12.025\nUgnat, 2004, Survival of women with breast cancer in Ottawa, Canada: variation with age, stage, histology, grade and treatment, Br J Canc, 90, 1138, 10.1038\u002Fsj.bjc.6601662\nBooth, 2010, The impact of socioeconomic status on stage of cancer at diagnosis and survival: a population-based study in Ontario, Canada, Cancer, 116, 4160, 10.1002\u002Fcncr.25427\nGorey, 2008, Cancer survival in Ontario, 1986-2003: evidence of equitable advances across most diverse urban and rural places, Can J Public Health, 99, 12, 10.1007\u002FBF03403733\nMcLaughlin, 2012, Effect on survival of longer intervals between confirmed diagnosis and treatment initiation among low-income women with breast cancer, J Clin Oncol, 30, 4493, 10.1200\u002FJCO.2012.39.7695\nCancer Care Ontario, 2016\nBlack, 2002, All-cause mortality in randomized trials of cancer screening, J Natl Cancer Inst, 94, 167, 10.1093\u002Fjnci\u002F94.3.167",{"VOID":1348},"10.1016\u002Fj.breast.2018.06.007","2024-05-15T17:10:29.546+00:00","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0960977618301188",[1352,1367,1389,1413,1435,1450,1463,1476,1489,1504,1519,1535,1550,1566,1582,1598,1620,1635,1651,1667],{"id":1353,"sortIndex":19,"researcher":18,"roles":1354,"affiliations":1355,"properties":1364,"displayName":1366,"givenName":18,"familyName":18},"94ce614e-13b7-4f13-b241-f5a9577b6546",[118],[1356],{"id":1357,"sortIndex":19,"affiliation":1358,"properties":18},"2f7cc47f-c8d2-445f-8c65-f741a5a521c1",{"id":1357,"createTime":18,"updateTime":18,"relativeEntities":1359,"slug":18,"properties":1360,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":1363,"statistic":18},[],{"title":1361},{"VI":1362},"Prevention and Cancer Control, Cancer Care Ontario, 620 University Avenue Toronto, Ontario M5G 2L7, Canada",[],{"title":1365},{"VI":1366},"Courtney R. Smith",{"id":1368,"sortIndex":135,"researcher":18,"roles":1369,"affiliations":1370,"properties":1386,"displayName":1388,"givenName":18,"familyName":18},"6337ff32-b3ee-4893-b2c9-915a01e302f4",[118],[1371,1377],{"id":1357,"sortIndex":19,"affiliation":1372,"properties":18},{"id":1357,"createTime":18,"updateTime":18,"relativeEntities":1373,"slug":18,"properties":1374,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":1376,"statistic":18},[],{"title":1375},{"VI":1362},[],{"id":1378,"sortIndex":135,"affiliation":1379,"properties":1385},"4fb741e7-fad8-4c8c-ae37-fda47d5c2352",{"id":1378,"createTime":18,"updateTime":18,"relativeEntities":1380,"slug":18,"properties":1381,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":1384,"statistic":18},[],{"title":1382},{"VI":1383},"Dalla Lana School of Public Health, University of Toronto, 155 College Street, 6th floor, Toronto, Ontario M5T 3M7, Canada",[],{},{"title":1387},{"VI":1388},"Anna M. Chiarelli",{"id":1390,"sortIndex":151,"researcher":18,"roles":1391,"affiliations":1392,"properties":1410,"displayName":1412,"givenName":18,"familyName":18},"31c4344f-2afd-4491-a75b-5987267a6cb7",[118],[1393,1401],{"id":1394,"sortIndex":19,"affiliation":1395,"properties":18},"82382c0c-977e-402e-bbec-dea06a17d627",{"id":1394,"createTime":18,"updateTime":18,"relativeEntities":1396,"slug":18,"properties":1397,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":1400,"statistic":18},[],{"title":1398},{"VI":1399},"Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, Ontario M4N 3M5, Canada",[],{"id":1402,"sortIndex":135,"affiliation":1403,"properties":1409},"41087f5c-9497-476f-a728-12edcbd75072",{"id":1402,"createTime":18,"updateTime":18,"relativeEntities":1404,"slug":18,"properties":1405,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":1408,"statistic":18},[],{"title":1406},{"VI":1407},"Department of Surgery, University of Toronto, 149 College Street, 5th Floor, Toronto, Ontario M5T 1P5, Canada",[],{},{"title":1411},{"VI":1412},"Claire MB. Holloway",{"id":1414,"sortIndex":167,"researcher":18,"roles":1415,"affiliations":1416,"properties":1432,"displayName":1434,"givenName":18,"familyName":18},"73396a96-5de0-42fd-b8e6-bb7b2c166826",[118],[1417,1423],{"id":1378,"sortIndex":19,"affiliation":1418,"properties":18},{"id":1378,"createTime":18,"updateTime":18,"relativeEntities":1419,"slug":18,"properties":1420,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":1422,"statistic":18},[],{"title":1421},{"VI":1383},[],{"id":1424,"sortIndex":135,"affiliation":1425,"properties":1431},"d0143fa0-cbc4-4090-a060-0d09e11f7f6b",{"id":1424,"createTime":18,"updateTime":18,"relativeEntities":1426,"slug":18,"properties":1427,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":1430,"statistic":18},[],{"title":1428},{"VI":1429},"Phoenix Children's Hospital, 1919 East Thomas Road, Phoenix, AZ 85016, United States",[],{},{"title":1433},{"VI":1434},"Lucia Mirea",{"id":1436,"sortIndex":183,"researcher":18,"roles":1437,"affiliations":1438,"properties":1447,"displayName":1449,"givenName":18,"familyName":18},"80b4271f-4f7f-4f2d-a1ce-eb2d849eb7ae",[118],[1439],{"id":1440,"sortIndex":19,"affiliation":1441,"properties":18},"bb39bc9a-411d-4969-8224-65471f395744",{"id":1440,"createTime":18,"updateTime":18,"relativeEntities":1442,"slug":18,"properties":1443,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":1446,"statistic":18},[],{"title":1444},{"VI":1445},"Department of Laboratory Medicine, St. Michael's Hospital, 30 Bond Street, Toronto, Ontario M5B 1W8, Canada",[],{"title":1448},{"VI":1449},"Frances P. O'Malley",{"id":1451,"sortIndex":197,"researcher":18,"roles":1452,"affiliations":1453,"properties":1460,"displayName":1462,"givenName":18,"familyName":18},"e8ebb4ef-f3fc-4e1c-80de-5e5ad41650e0",[118],[1454],{"id":1357,"sortIndex":19,"affiliation":1455,"properties":18},{"id":1357,"createTime":18,"updateTime":18,"relativeEntities":1456,"slug":18,"properties":1457,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":1459,"statistic":18},[],{"title":1458},{"VI":1362},[],{"title":1461},{"VI":1462},"Kristina M. Blackmore",{"id":1464,"sortIndex":211,"researcher":18,"roles":1465,"affiliations":1466,"properties":1473,"displayName":1475,"givenName":18,"familyName":18},"03f79a3c-fc55-45d9-8be7-aea930b1dff5",[118],[1467],{"id":1357,"sortIndex":19,"affiliation":1468,"properties":18},{"id":1357,"createTime":18,"updateTime":18,"relativeEntities":1469,"slug":18,"properties":1470,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":1472,"statistic":18},[],{"title":1471},{"VI":1362},[],{"title":1474},{"VI":1475},"Anjali Pandya",{"id":1477,"sortIndex":225,"researcher":18,"roles":1478,"affiliations":1479,"properties":1486,"displayName":1488,"givenName":18,"familyName":18},"b163bdd8-315e-4512-b883-557002297c97",[118],[1480],{"id":1357,"sortIndex":19,"affiliation":1481,"properties":18},{"id":1357,"createTime":18,"updateTime":18,"relativeEntities":1482,"slug":18,"properties":1483,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":1485,"statistic":18},[],{"title":1484},{"VI":1362},[],{"title":1487},{"VI":1488},"Vicky Majpruz",{"id":1490,"sortIndex":239,"researcher":18,"roles":1491,"affiliations":1492,"properties":1501,"displayName":1503,"givenName":18,"familyName":18},"eb97c717-622e-45bb-9078-cced50a2fc9b",[118],[1493],{"id":1494,"sortIndex":19,"affiliation":1495,"properties":18},"7c55a942-0101-4b1c-a8e3-d0e91802bb7e",{"id":1494,"createTime":18,"updateTime":18,"relativeEntities":1496,"slug":18,"properties":1497,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":1500,"statistic":18},[],{"title":1498},{"VI":1499},"Prevention and Screening Services, Northwestern Ontario, 980 Oliver Road, Thunder Bay, ON, Canada P7B 6V4",[],{"title":1502},{"VI":1503},"Cathy Paroschy Harris",{"id":1505,"sortIndex":253,"researcher":18,"roles":1506,"affiliations":1507,"properties":1516,"displayName":1518,"givenName":18,"familyName":18},"1f6a2428-caee-45fa-bc33-acc8bc1c148d",[118],[1508],{"id":1509,"sortIndex":19,"affiliation":1510,"properties":18},"6107c53e-d8e5-4948-afe2-b13c35c7666d",{"id":1509,"createTime":18,"updateTime":18,"relativeEntities":1511,"slug":18,"properties":1512,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":1515,"statistic":18},[],{"title":1513},{"VI":1514},"South East Regional Cancer Program, 25 King Street West Kingston, Ontario K7L 5P9, Canada",[],{"title":1517},{"VI":1518},"Ashley Hendry",{"id":1520,"sortIndex":1521,"researcher":18,"roles":1522,"affiliations":1523,"properties":1532,"displayName":1534,"givenName":18,"familyName":18},"1aa931fc-6f82-4676-a1b5-cd87cf863d2b",10,[118],[1524],{"id":1525,"sortIndex":19,"affiliation":1526,"properties":18},"281d68f6-f6ac-4626-976d-bddf3a0f80df",{"id":1525,"createTime":18,"updateTime":18,"relativeEntities":1527,"slug":18,"properties":1528,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":1531,"statistic":18},[],{"title":1529},{"VI":1530},"North East Regional Cancer Program, 41 Ramsey Lake Road, Sudbury, ON P3E 5J1, Canada",[],{"title":1533},{"VI":1534},"Amanda Hey",{"id":1536,"sortIndex":683,"researcher":18,"roles":1537,"affiliations":1538,"properties":1547,"displayName":1549,"givenName":18,"familyName":18},"0cd10f4e-692f-41c8-9b24-c73ebd200343",[118],[1539],{"id":1540,"sortIndex":19,"affiliation":1541,"properties":18},"41d811b1-29bc-4e02-8e18-792fe1756541",{"id":1540,"createTime":18,"updateTime":18,"relativeEntities":1542,"slug":18,"properties":1543,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":1546,"statistic":18},[],{"title":1544},{"VI":1545},"South West Regional Cancer Program, 790 Commissioners Road East London, Ontario N6A 4L6, Canada",[],{"title":1548},{"VI":1549},"Anat Kornecki",{"id":1551,"sortIndex":1552,"researcher":18,"roles":1553,"affiliations":1554,"properties":1563,"displayName":1565,"givenName":18,"familyName":18},"8828a46a-d777-4225-93d2-f0fe88a2b24b",12,[118],[1555],{"id":1556,"sortIndex":19,"affiliation":1557,"properties":18},"a442aecc-b08a-4b52-9ee3-3169bb879f78",{"id":1556,"createTime":18,"updateTime":18,"relativeEntities":1558,"slug":18,"properties":1559,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":1562,"statistic":18},[],{"title":1560},{"VI":1561},"North Simcoe Muskoka Regional Cancer Program, 201 Georgian Drive Barrie, ON L4M 6M2, Canada",[],{"title":1564},{"VI":1565},"George Lougheed",{"id":1567,"sortIndex":1568,"researcher":18,"roles":1569,"affiliations":1570,"properties":1579,"displayName":1581,"givenName":18,"familyName":18},"ec926d90-5fc6-4272-8e4e-6492292e40d7",13,[118],[1571],{"id":1572,"sortIndex":19,"affiliation":1573,"properties":18},"5712bb12-4f6c-4acd-8f01-7509f113d926",{"id":1572,"createTime":18,"updateTime":18,"relativeEntities":1574,"slug":18,"properties":1575,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":1578,"statistic":18},[],{"title":1576},{"VI":1577},"Waterloo Wellington Regional Cancer Program, 835 King Street West Kitchener, Ontario N2G 1G3, Canada",[],{"title":1580},{"VI":1581},"Barbara-Anne Maier",{"id":1583,"sortIndex":1584,"researcher":18,"roles":1585,"affiliations":1586,"properties":1595,"displayName":1597,"givenName":18,"familyName":18},"d2cda0fc-491c-4df0-a469-69b5036e1fe4",14,[118],[1587],{"id":1588,"sortIndex":19,"affiliation":1589,"properties":18},"299477db-5b6c-47ec-a30c-1f3988c32f3c",{"id":1588,"createTime":18,"updateTime":18,"relativeEntities":1590,"slug":18,"properties":1591,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":1594,"statistic":18},[],{"title":1592},{"VI":1593},"Central East Regional Cancer Program, 1 Hospital Court Oshawa, ON L1G 2B9, Canada",[],{"title":1596},{"VI":1597},"Patricia Marchand",{"id":1599,"sortIndex":315,"researcher":18,"roles":1600,"affiliations":1601,"properties":1617,"displayName":1619,"givenName":18,"familyName":18},"43f4e9ef-36f5-460b-ae7b-dddec4301321",[118],[1602,1608],{"id":1402,"sortIndex":19,"affiliation":1603,"properties":18},{"id":1402,"createTime":18,"updateTime":18,"relativeEntities":1604,"slug":18,"properties":1605,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":1607,"statistic":18},[],{"title":1606},{"VI":1407},[],{"id":1609,"sortIndex":135,"affiliation":1610,"properties":1616},"66cec5d9-d31e-45dd-a11a-babac6cd0aec",{"id":1609,"createTime":18,"updateTime":18,"relativeEntities":1611,"slug":18,"properties":1612,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":1615,"statistic":18},[],{"title":1613},{"VI":1614},"Princess Margaret Cancer Centre, 610 University Avenue, Toronto, Ontario, M5G 2M9, Canada",[],{},{"title":1618},{"VI":1619},"David McCready",{"id":1621,"sortIndex":1013,"researcher":18,"roles":1622,"affiliations":1623,"properties":1632,"displayName":1634,"givenName":18,"familyName":18},"2f8d5656-4940-4adb-905d-f268bc0bd772",[118],[1624],{"id":1625,"sortIndex":19,"affiliation":1626,"properties":18},"349ff150-8c02-4e50-8fdb-76a5a29c899a",{"id":1625,"createTime":18,"updateTime":18,"relativeEntities":1627,"slug":18,"properties":1628,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":1631,"statistic":18},[],{"title":1629},{"VI":1630},"Hamilton Niagara Haldimand Brant Regional Cancer Program, 699 Concession Street Hamilton, Ontario L8V 5C2, Canada",[],{"title":1633},{"VI":1634},"Carol Rand",{"id":1636,"sortIndex":1637,"researcher":18,"roles":1638,"affiliations":1639,"properties":1648,"displayName":1650,"givenName":18,"familyName":18},"17857dee-3be6-4fad-bfd9-e9999fe4e046",17,[118],[1640],{"id":1641,"sortIndex":19,"affiliation":1642,"properties":18},"9f21da5c-693a-4863-a0e8-98c9942f9729",{"id":1641,"createTime":18,"updateTime":18,"relativeEntities":1643,"slug":18,"properties":1644,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":1647,"statistic":18},[],{"title":1645},{"VI":1646},"North York General Hospital, 4001 Leslie St, North York, ON, M2K 1E1, Canada",[],{"title":1649},{"VI":1650},"Simon Raphael",{"id":1652,"sortIndex":1653,"researcher":18,"roles":1654,"affiliations":1655,"properties":1664,"displayName":1666,"givenName":18,"familyName":18},"e88dc1d1-ce74-44b0-9560-7079e248d527",18,[118],[1656],{"id":1657,"sortIndex":19,"affiliation":1658,"properties":18},"7ff9a92a-bb26-46b6-a4b2-1c1fb47bd4f2",{"id":1657,"createTime":18,"updateTime":18,"relativeEntities":1659,"slug":18,"properties":1660,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":1663,"statistic":18},[],{"title":1661},{"VI":1662},"Champlain Regional Cancer Program, 501 Smyth Road Ottawa, Ontario K1H 8L6, Canada",[],{"title":1665},{"VI":1666},"Roanne Segal-Nadler",{"id":1668,"sortIndex":1669,"researcher":18,"roles":1670,"affiliations":1671,"properties":1680,"displayName":1682,"givenName":18,"familyName":18},"c8f59079-f6cc-410c-bbec-bda4604b1b2f",19,[118],[1672],{"id":1673,"sortIndex":19,"affiliation":1674,"properties":18},"7a9ccde1-0e4e-4f65-8374-6596dcdbcb62",{"id":1673,"createTime":18,"updateTime":18,"relativeEntities":1675,"slug":18,"properties":1676,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":1679,"statistic":18},[],{"title":1677},{"VI":1678},"Erie St. Clair Regional Cancer Program, 2220 Kildare Road Windsor, Ontario N8W 2X3, Canada",[],{"title":1681},{"VI":1682},"Neelu Sehgal",{"url":1350,"publisher":1684,"properties":1727},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":1685,"slug":10,"properties":1686,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":1689,"manageAffiliations":1706,"indexDatabases":1712,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":1687,"title":1688},{"VOID":13},{"EN":15},[1690,1694,1698,1702],{"id":22,"createTime":18,"updateTime":18,"relativeEntities":1691,"label":1692,"description":1693,"parentId":18,"standard":18,"scholarHubFieldId":18},[],{"EN":25},{},{"id":28,"createTime":18,"updateTime":18,"relativeEntities":1695,"label":1696,"description":1697,"parentId":18,"standard":18,"scholarHubFieldId":18},[],{"EN":31},{},{"id":34,"createTime":18,"updateTime":18,"relativeEntities":1699,"label":1700,"description":1701,"parentId":18,"standard":18,"scholarHubFieldId":18},[],{"EN":37},{},{"id":40,"createTime":18,"updateTime":18,"relativeEntities":1703,"label":1704,"description":1705,"parentId":18,"standard":18,"scholarHubFieldId":18},[],{"EN":43},{},[1707],{"id":47,"createTime":18,"updateTime":18,"relativeEntities":1708,"slug":18,"properties":1709,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":1711,"statistic":18},[],{"title":1710},{"EN":51},[],[1713,1720],{"id":55,"indexDatabase":1714,"url":68,"indexYears":18,"academicFieldIds":1719,"indexDatabaseRanking":18},{"id":57,"createTime":18,"updateTime":18,"relativeEntities":1715,"label":1716,"description":1717,"key":64,"publicationTags":1718,"standard":18},[],{"EN":60,"VI":60},{"EN":62,"VI":63},[66,67],[70,71],{"id":73,"indexDatabase":1721,"url":84,"indexYears":85,"academicFieldIds":1726,"indexDatabaseRanking":91},{"id":75,"createTime":18,"updateTime":18,"relativeEntities":1722,"label":1723,"description":1724,"key":81,"publicationTags":1725,"standard":18},[],{"EN":78,"VI":78},{"EN":78,"VI":80},[83],[87,88,89,90],{"pages":1728,"volume":1730},{"VOID":1729},"25-33",{"VOID":1731},"41",{"total":167,"publishYear":1733,"statisticByYear":1734},2018,{"2019":151,"2020":135},"2018-10-01","2026-07-17T15:48:54.902+00:00",[66,91],{"id":1739,"createTime":1740,"updateTime":1741,"relativeEntities":1742,"slug":1743,"properties":1744,"entityType":109,"verifyStatus":110,"verifyTime":1751,"verifyNote":112,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":1752,"fullTextUrl":18,"authors":1753,"publicationType":265,"publisherRelationship":1881,"citationCount":19,"citationInfo":1930,"publishDate":1933,"publishYear":1931,"citationAnalyzeStatus":320,"lastCitationAnalyze":1934,"indexDatabases":1935,"openAccess":18,"references":1936,"isForceReanalyzing":399},"c36457d5-a48b-42d1-8018-b7f61b9849bb","2024-01-03T08:27:33.712+00:00","2026-07-13T08:49:46.255+00:00",[],"Prevalence-of-self-reported-arm-morbidity-following-treatment-for-breast-cancer-in-the-Australian-Breast-Cancer-Family-Study",{"title":1745,"gsPaper":1747,"doi":1749},{"EN":1746},"Prevalence of self-reported arm morbidity following treatment for breast cancer in the Australian Breast Cancer Family Study",{"VOID":1748},"[\"11927830934126604312\"]",{"VOID":1750},"10.1054\u002Fbrst.2000.0291","2024-04-27T11:03:17.498+00:00","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0960977600902911",[1754,1778,1795,1808,1821,1838,1853,1868],{"id":1755,"sortIndex":19,"researcher":18,"roles":1756,"affiliations":1757,"properties":1775,"displayName":1777,"givenName":18,"familyName":18},"db11c445-8de8-421e-a002-1b34cfececa0",[118],[1758,1766],{"id":1759,"sortIndex":19,"affiliation":1760,"properties":18},"1125a5a0-50a2-4b61-a7ab-bd4cbe52ed0f",{"id":1759,"createTime":18,"updateTime":18,"relativeEntities":1761,"slug":18,"properties":1762,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":1765,"statistic":18},[],{"title":1763},{"VI":1764},"Department of Preventive and Social Medicine, University of Otago, Dunedin, New Zealand",[],{"id":1767,"sortIndex":135,"affiliation":1768,"properties":1774},"98596f50-015c-4b18-b8a7-53c1b98f84f8",{"id":1767,"createTime":18,"updateTime":18,"relativeEntities":1769,"slug":18,"properties":1770,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":1773,"statistic":18},[],{"title":1771},{"VI":1772},"Cancer Epidemiology Research Unit, New South Wales Cancer Council, Sydney",[],{},{"title":1776},{"VI":1777},"M.R.E. McCredie",{"id":1779,"sortIndex":135,"researcher":18,"roles":1780,"affiliations":1781,"properties":1790,"displayName":1792,"givenName":18,"familyName":18},"25f3ebf7-7451-4a2c-8e0a-581c8fa33166",[118],[1782],{"id":1783,"sortIndex":19,"affiliation":1784,"properties":18},"a3e7d6d6-fd0b-4883-99f1-3c524e2a8a4b",{"id":1783,"createTime":18,"updateTime":18,"relativeEntities":1785,"slug":18,"properties":1786,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":1789,"statistic":18},[],{"title":1787},{"VI":1788},"Centre for Genetic Epidemiology, University of Melbourne",[],{"title":1791,"gsAuthor":1793},{"VI":1792},"G.S. Dite",{"VOID":1794},"[\"fonEP6MAAAAJ\"]",{"id":1796,"sortIndex":151,"researcher":18,"roles":1797,"affiliations":1798,"properties":1805,"displayName":1807,"givenName":18,"familyName":18},"4da12691-b932-4605-ac0e-f65b8ad09c94",[118],[1799],{"id":1767,"sortIndex":19,"affiliation":1800,"properties":18},{"id":1767,"createTime":18,"updateTime":18,"relativeEntities":1801,"slug":18,"properties":1802,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":1804,"statistic":18},[],{"title":1803},{"VI":1772},[],{"title":1806},{"VI":1807},"L. Porter",{"id":1809,"sortIndex":167,"researcher":18,"roles":1810,"affiliations":1811,"properties":1818,"displayName":1820,"givenName":18,"familyName":18},"3c233ee0-2af3-4012-92a6-c1cd8229fb12",[118],[1812],{"id":1783,"sortIndex":19,"affiliation":1813,"properties":18},{"id":1783,"createTime":18,"updateTime":18,"relativeEntities":1814,"slug":18,"properties":1815,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":1817,"statistic":18},[],{"title":1816},{"VI":1788},[],{"title":1819},{"VI":1820},"J. Maskiell",{"id":1822,"sortIndex":183,"researcher":18,"roles":1823,"affiliations":1824,"properties":1833,"displayName":1835,"givenName":18,"familyName":18},"17eaa0ee-6621-4ce5-919d-b2adaea14f55",[118],[1825],{"id":1826,"sortIndex":19,"affiliation":1827,"properties":18},"38ece0d5-202d-43f8-b19f-9b26bef2c32a",{"id":1826,"createTime":18,"updateTime":18,"relativeEntities":1828,"slug":18,"properties":1829,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":1832,"statistic":18},[],{"title":1830},{"VI":1831},"Cancer Epidemiology Centre, Anti-Cancer Council of Victoria, Melbourne",[],{"title":1834,"gsAuthor":1836},{"VI":1835},"G.G. Giles",{"VOID":1837},"[\"ROUlvw0AAAAJ\"]",{"id":1839,"sortIndex":197,"researcher":18,"roles":1840,"affiliations":1841,"properties":1850,"displayName":1852,"givenName":18,"familyName":18},"90fe4370-91e6-4449-888d-fe387e038985",[118],[1842],{"id":1843,"sortIndex":19,"affiliation":1844,"properties":18},"a8ac9a6e-f8b0-45f0-a600-3a25102f9282",{"id":1843,"createTime":18,"updateTime":18,"relativeEntities":1845,"slug":18,"properties":1846,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":1849,"statistic":18},[],{"title":1847},{"VI":1848},"Department of Haematology and Medical Oncology, Peter MacCallum Cancer Institute, Melbourne",[],{"title":1851},{"VI":1852},"K.-A. Phillips",{"id":1854,"sortIndex":211,"researcher":18,"roles":1855,"affiliations":1856,"properties":1865,"displayName":1867,"givenName":18,"familyName":18},"f13ef945-003b-4690-8beb-043749ecb30a",[118],[1857],{"id":1858,"sortIndex":19,"affiliation":1859,"properties":18},"97127275-0911-4df8-ab10-580c65a87d29",{"id":1858,"createTime":18,"updateTime":18,"relativeEntities":1860,"slug":18,"properties":1861,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":1864,"statistic":18},[],{"title":1862},{"VI":1863},"NHMRC National Breast Cancer Centre, Sydney, Australia",[],{"title":1866},{"VI":1867},"S. Redman",{"id":1869,"sortIndex":225,"researcher":18,"roles":1870,"affiliations":1871,"properties":1878,"displayName":1880,"givenName":18,"familyName":18},"a4ae937a-cda2-41cd-9d00-b6040ace0395",[118],[1872],{"id":1783,"sortIndex":19,"affiliation":1873,"properties":18},{"id":1783,"createTime":18,"updateTime":18,"relativeEntities":1874,"slug":18,"properties":1875,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":1877,"statistic":18},[],{"title":1876},{"VI":1788},[],{"title":1879},{"VI":1880},"J.L. Hopper",{"url":1752,"publisher":1882,"properties":1925},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":1883,"slug":10,"properties":1884,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":1887,"manageAffiliations":1904,"indexDatabases":1910,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":1885,"title":1886},{"VOID":13},{"EN":15},[1888,1892,1896,1900],{"id":22,"createTime":18,"updateTime":18,"relativeEntities":1889,"label":1890,"description":1891,"parentId":18,"standard":18,"scholarHubFieldId":18},[],{"EN":25},{},{"id":28,"createTime":18,"updateTime":18,"relativeEntities":1893,"label":1894,"description":1895,"parentId":18,"standard":18,"scholarHubFieldId":18},[],{"EN":31},{},{"id":34,"createTime":18,"updateTime":18,"relativeEntities":1897,"label":1898,"description":1899,"parentId":18,"standard":18,"scholarHubFieldId":18},[],{"EN":37},{},{"id":40,"createTime":18,"updateTime":18,"relativeEntities":1901,"label":1902,"description":1903,"parentId":18,"standard":18,"scholarHubFieldId":18},[],{"EN":43},{},[1905],{"id":47,"createTime":18,"updateTime":18,"relativeEntities":1906,"slug":18,"properties":1907,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":1909,"statistic":18},[],{"title":1908},{"EN":51},[],[1911,1918],{"id":55,"indexDatabase":1912,"url":68,"indexYears":18,"academicFieldIds":1917,"indexDatabaseRanking":18},{"id":57,"createTime":18,"updateTime":18,"relativeEntities":1913,"label":1914,"description":1915,"key":64,"publicationTags":1916,"standard":18},[],{"EN":60,"VI":60},{"EN":62,"VI":63},[66,67],[70,71],{"id":73,"indexDatabase":1919,"url":84,"indexYears":85,"academicFieldIds":1924,"indexDatabaseRanking":91},{"id":75,"createTime":18,"updateTime":18,"relativeEntities":1920,"label":1921,"description":1922,"key":81,"publicationTags":1923,"standard":18},[],{"EN":78,"VI":78},{"EN":78,"VI":80},[83],[87,88,89,90],{"pages":1926,"volume":1928},{"VOID":1927},"515-522",{"VOID":1929},"10",{"total":19,"publishYear":1931,"statisticByYear":1932},2001,{},"2001-12-01","2026-07-13T08:49:46.254+00:00",[66,91],[1937,1943,1948,1952,1960,1968,1971,1980,1988,1991,1994,2002,2009,2016,2021,2027,2031,2034,2037,2041,2047,2055,2059,2062,2069],{"id":18,"text":1938,"url":1939,"identifiers":1940},"Mortimer, 1998, The pathophysiology of lymphedema, Cancer, 83, 2798, 10.1002\u002F(SICI)1097-0142(19981215)83:12B+\u003C2798::AID-CNCR28>3.0.CO;2-E","https:\u002F\u002Fdoi.org\u002F10.1002\u002F(sici)1097-0142(19981215)83:12b+\u003C2798::aid-cncr28>3.0.co;2-e",{"openalex":1941,"doi":1942},"W4297040194","10.1002\u002F(sici)1097-0142(19981215)83:12b+",{"id":18,"text":1944,"url":1945,"identifiers":1946},"Rockson, 1998, Precipitating factors in lymphedema: myths and realities, Cancer, 83, 2814, 10.1002\u002F(SICI)1097-0142(19981215)83:12B+\u003C2814::AID-CNCR31>3.0.CO;2-E","https:\u002F\u002Fdoi.org\u002F10.1002\u002F(sici)1097-0142(19981215)83:12b+\u003C2814::aid-cncr31>3.0.co;2-e",{"openalex":1947,"doi":1942},"W4366064431",{"id":18,"text":1949,"url":18,"identifiers":1950},"Tobin, 1993, The psychological morbidity of cancer-related arm swelling, Cancer, 72, 3248, 10.1002\u002F1097-0142(19931201)72:11\u003C3248::AID-CNCR2820721119>3.0.CO;2-Z",{"doi":1951},"10.1002\u002F1097-0142(19931201)72:11\u003C3248::AID-CNCR2820721119>3.0.CO;2-Z",{"id":18,"text":1953,"url":1954,"identifiers":1955},"Britton, 1962, Causes and treatment of postmastectomy lymphedema of the arm, JAMA, 180, 95, 10.1001\u002Fjama.1962.03050150001001","https:\u002F\u002Fdoi.org\u002F10.1001\u002Fjama.1962.03050150001001",{"mag":1956,"openalex":1957,"pm":1958,"doi":1959},"1998939583","W1998939583","13873187","10.1001\u002Fjama.1962.03050150001001",{"id":18,"text":1961,"url":1962,"identifiers":1963},"Kissin, 1986, Risk of lymphoedema following treatment for breast cancer, Br J Surg, 73, 580, 10.1002\u002Fbjs.1800730723","https:\u002F\u002Fdoi.org\u002F10.1002\u002Fbjs.1800730723",{"mag":1964,"openalex":1965,"pm":1966,"doi":1967},"1994490715","W1994490715","3730795","10.1002\u002Fbjs.1800730723",{"id":350,"text":1969,"url":352,"identifiers":1970},"Ball, 1992, Radical axillary dissection in the staging and treatment of breast cancer, Ann R Coll Surg Engl, 74, 126",{"doi":354},{"id":18,"text":1972,"url":1973,"identifiers":1974},"Ivens, 1992, Assessment of morbidity from complete axillary dissection, Br J Cancer, 66, 136, 10.1038\u002Fbjc.1992.230","https:\u002F\u002Fdoi.org\u002F10.1038\u002Fbjc.1992.230",{"mag":1975,"pmc":1976,"openalex":1977,"pm":1978,"doi":1979},"2091408381","1977908","W2091408381","1637663","10.1038\u002Fbjc.1992.230",{"id":18,"text":1981,"url":1982,"identifiers":1983},"Lin, 1993, Impact of axillary lymph node dissection on the therapy of breast cancer patients, J Clin Oncol, 11, 1536, 10.1200\u002FJCO.1993.11.8.1536","https:\u002F\u002Fdoi.org\u002F10.1200\u002Fjco.1993.11.8.1536",{"mag":1984,"openalex":1985,"pm":1986,"doi":1987},"1907119325","W1907119325","8336192","10.1200\u002Fjco.1993.11.8.1536",{"id":350,"text":1989,"url":352,"identifiers":1990},"Ferrandez, 1996, Frequency of lymphedema of the upper limb after treatment of breast cancer. Risk factors. Apropos of 683 cases, Bull Cancer, 83, 989",{"doi":354},{"id":18,"text":1992,"url":18,"identifiers":1993},"Schunemann, Lymphedema after breast carcinoma. A study of 5868 cases, Deutsch Med Wschr, 122, 536",{},{"id":18,"text":1995,"url":1996,"identifiers":1997},"Werner, 1991, Arm edema in conservatively managed breast cancer: obesity is a major predictive factor, Ther Radiol, 180, 177, 10.1148\u002Fradiology.180.1.2052688","https:\u002F\u002Fdoi.org\u002F10.1148\u002Fradiology.180.1.2052688",{"mag":1998,"openalex":1999,"pm":2000,"doi":2001},"2085871594","W2085871594","2052688","10.1148\u002Fradiology.180.1.2052688",{"id":18,"text":2003,"url":2004,"identifiers":2005},"Mortimer, 1996, The prevalence of arm oedema following treatment for breast cancer, Q J M, 89, 377, 10.1093\u002Fqjmed\u002F89.5.377","https:\u002F\u002Fdoi.org\u002F10.1093\u002Fqjmed\u002F89.5.377",{"mag":2006,"openalex":2007,"doi":2008},"1970084290","W1970084290","10.1093\u002Fqjmed\u002F89.5.377",{"id":18,"text":2010,"url":2011,"identifiers":2012},"Paci, 1996, Long-term sequelae of breast cancer surgery, Tumori, 82, 321, 10.1177\u002F030089169608200405","https:\u002F\u002Fdoi.org\u002F10.1177\u002F030089169608200405",{"openalex":2013,"pm":2014,"doi":2015},"W4299896925","8890963","10.1177\u002F030089169608200405",{"id":18,"text":2017,"url":2018,"identifiers":2019},"Suneson, 1996, Clinical incidence of lymphoedema in breast cancer patients in Jönköping County, Sweden, Eur J Cancer Care (Engl Lang Ed), 5, 7, 10.1111\u002Fj.1365-2354.1996.tb00199.x","http:\u002F\u002Fdx.doi.org\u002F10.1111\u002Fj.1365-2354.1996.tb00199.x",{"doi":2020},"10.1111\u002Fj.1365-2354.1996.tb00199.x",{"id":2022,"text":2023,"url":2024,"identifiers":2025},"61a25060-036d-4827-90e1-0db979caf353","Hopper, 1994, Background, rationale and protocol for a case-control-family study of breast cancer, The Breast, 3, 79, 10.1016\u002F0960-9776(94)90003-5","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002F0960977694900035",{"doi":2026},"10.1016\u002F0960-9776(94)90003-5",{"id":18,"text":2028,"url":18,"identifiers":2029},"McCredie, 1998, Breast cancer in Australian women under the age of 40, Cancer Causes Control, 9, 189, 10.1023\u002FA:1008886328352",{"doi":2030},"10.1023\u002FA:1008886328352",{"id":18,"text":2032,"url":18,"identifiers":2033},"1999",{},{"id":18,"text":2035,"url":18,"identifiers":2036},"1995",{},{"id":18,"text":2038,"url":18,"identifiers":2039},"Edwards, 2000, Prevalence and aetiology of lymphoedema after breast cancer treatment in southern Tasmania, Aust NZ J Surg, 70, 412, 10.1046\u002Fj.1440-1622.2000.01839.x",{"doi":2040},"10.1046\u002Fj.1440-1622.2000.01839.x",{"id":2042,"text":2043,"url":2044,"identifiers":2045},"70686e47-c317-4552-8442-dcdcca424021","Pezner, 1986, Arm lymphoedema in patients treated conservatively for breast cancer: relationship to patient age and axillary node dissection technique, Int J Radiation Oncology, Biology, Physics, 12, 2079, 10.1016\u002F0360-3016(86)90005-2","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002F0360301686900052",{"doi":2046},"10.1016\u002F0360-3016(86)90005-2",{"id":18,"text":2048,"url":2049,"identifiers":2050},"Olsen, 1990, Radiation induced brachial plexus neuropathy in breast cancer patients, Acta Oncol, 29, 885, 10.3109\u002F02841869009096384","https:\u002F\u002Fdoi.org\u002F10.3109\u002F02841869009096384",{"mag":2051,"openalex":2052,"pm":2053,"doi":2054},"2043828564","W2043828564","2261203","10.3109\u002F02841869009096384",{"id":18,"text":2056,"url":18,"identifiers":2057},"Clarysse, 1993, Lymphoedema following breast cancer treatment, Acta Clin Belg Suppl, 15, 47, 10.1080\u002F17843286.1993.11718353",{"doi":2058},"10.1080\u002F17843286.1993.11718353",{"id":18,"text":2060,"url":18,"identifiers":2061},"Hill, 1999",{},{"id":18,"text":2063,"url":2064,"identifiers":2065},"Krag, 1998, Development of sentinel node targeting technique in breast cancer patients, Breast J, 4, 67, 10.1046\u002Fj.1524-4741.1998.420067.x","https:\u002F\u002Fdoi.org\u002F10.1046\u002Fj.1524-4741.1998.420067.x",{"mag":2066,"openalex":2067,"doi":2068},"2049545273","W2049545273","10.1046\u002Fj.1524-4741.1998.420067.x",{"id":18,"text":2070,"url":2071,"identifiers":2072},"Chetty, 2000, Management of the axilla in operable breast cancer treated by breast conservation a randomised clinical trial, Br J Surg, 87, 163, 10.1046\u002Fj.1365-2168.2000.01345.x","http:\u002F\u002Fdx.doi.org\u002F10.1046\u002Fj.1365-2168.2000.01481-11.x",{"doi":2073},"10.1046\u002Fj.1365-2168.2000.01481-11.x",{"id":2075,"createTime":2076,"updateTime":2077,"relativeEntities":2078,"slug":2079,"properties":2080,"entityType":109,"verifyStatus":110,"verifyTime":2093,"verifyNote":112,"languages":2094,"translateLanguages":18,"viewCount":19,"primaryUrl":2095,"fullTextUrl":18,"authors":2096,"publicationType":265,"publisherRelationship":2156,"citationCount":19,"citationInfo":2206,"publishDate":2208,"publishYear":1931,"citationAnalyzeStatus":320,"lastCitationAnalyze":2209,"indexDatabases":2210,"openAccess":18,"references":2211,"isForceReanalyzing":399},"e099fc9e-11f3-4413-80b6-20642a9917fc","2024-09-05T17:36:54.555+00:00","2026-07-13T05:04:53.660+00:00",[],"Myofibroblastoma-and-solitary-fibrous-tumour-of-the-breast-histopathologic-and-immunohistochemical-studies",{"openalex":2081,"mag":2083,"title":2085,"gsPaper":2087,"pm":2089,"doi":2091},{"VOID":2082},"W2015554876",{"VOID":2084},"2015554876",{"EN":2086},"Myofibroblastoma and solitary fibrous tumour of the breast: histopathologic and immunohistochemical studies",{"VOID":2088},"[\"135953561502775974\"]",{"VOID":2090},"14965560",{"VOID":2092},"10.1054\u002Fbrst.2000.0188","2024-09-05T17:36:54.554+00:00",[811],"https:\u002F\u002Flinkinghub.elsevier.com\u002Fretrieve\u002Fpii\u002FS0960977600901887",[2097,2116,2139],{"id":2098,"sortIndex":19,"researcher":18,"roles":2099,"affiliations":2100,"properties":2109,"displayName":2113,"givenName":18,"familyName":18},"33cdf29a-e1cd-4c31-9593-15da1bc12562",[],[2101],{"id":2102,"sortIndex":19,"affiliation":2103,"properties":18},"a2922b24-6bf7-45c9-853d-d655c3bea02c",{"id":2102,"createTime":18,"updateTime":18,"relativeEntities":2104,"slug":18,"properties":2105,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":2108,"statistic":18},[],{"title":2106},{"VI":2107},"Department of Laboratory Medicine and Pathology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota USA",[],{"orcid":2110,"title":2112,"openalex":2114},{"VOID":2111},"https:\u002F\u002Forcid.org\u002F0000-0001-5066-9667",{"EN":2113},"Diva R. Salomão",{"VOID":2115},"A5049186993",{"id":2117,"sortIndex":135,"researcher":18,"roles":2118,"affiliations":2119,"properties":2134,"displayName":2136,"givenName":18,"familyName":18},"fe6e066e-7233-4b5e-87d5-9b17d575fc36",[],[2120,2126],{"id":2102,"sortIndex":19,"affiliation":2121,"properties":18},{"id":2102,"createTime":18,"updateTime":18,"relativeEntities":2122,"slug":18,"properties":2123,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":2125,"statistic":18},[],{"title":2124},{"VI":2107},[],{"id":2127,"sortIndex":135,"affiliation":2128,"properties":18},"c246a702-8e79-4e34-aa37-b696f73ae185",{"id":2127,"createTime":18,"updateTime":18,"relativeEntities":2129,"slug":18,"properties":2130,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":2133,"statistic":18},[],{"title":2131},{"EN":2132},"Present address: Department of Pathology, St. Vincents Hospital, Elm Park, Dublin 4, Ireland",[],{"title":2135,"openalex":2137},{"EN":2136},"Thomas B. Crotty",{"VOID":2138},"A5081818718",{"id":2140,"sortIndex":151,"researcher":18,"roles":2141,"affiliations":2142,"properties":2149,"displayName":2153,"givenName":18,"familyName":18},"4b3ca7aa-606b-4dfc-8ce8-4f0d4a2ca369",[],[2143],{"id":2102,"sortIndex":19,"affiliation":2144,"properties":18},{"id":2102,"createTime":18,"updateTime":18,"relativeEntities":2145,"slug":18,"properties":2146,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":2148,"statistic":18},[],{"title":2147},{"VI":2107},[],{"orcid":2150,"title":2152,"openalex":2154},{"VOID":2151},"https:\u002F\u002Forcid.org\u002F0000-0002-6052-7299",{"EN":2153},"Antonio G. Nascimento",{"VOID":2155},"A5032183157",{"url":18,"publisher":2157,"properties":2200},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":2158,"slug":10,"properties":2159,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":2162,"manageAffiliations":2179,"indexDatabases":2185,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":2160,"title":2161},{"VOID":13},{"EN":15},[2163,2167,2171,2175],{"id":22,"createTime":18,"updateTime":18,"relativeEntities":2164,"label":2165,"description":2166,"parentId":18,"standard":18,"scholarHubFieldId":18},[],{"EN":25},{},{"id":28,"createTime":18,"updateTime":18,"relativeEntities":2168,"label":2169,"description":2170,"parentId":18,"standard":18,"scholarHubFieldId":18},[],{"EN":31},{},{"id":34,"createTime":18,"updateTime":18,"relativeEntities":2172,"label":2173,"description":2174,"parentId":18,"standard":18,"scholarHubFieldId":18},[],{"EN":37},{},{"id":40,"createTime":18,"updateTime":18,"relativeEntities":2176,"label":2177,"description":2178,"parentId":18,"standard":18,"scholarHubFieldId":18},[],{"EN":43},{},[2180],{"id":47,"createTime":18,"updateTime":18,"relativeEntities":2181,"slug":18,"properties":2182,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":2184,"statistic":18},[],{"title":2183},{"EN":51},[],[2186,2193],{"id":55,"indexDatabase":2187,"url":68,"indexYears":18,"academicFieldIds":2192,"indexDatabaseRanking":18},{"id":57,"createTime":18,"updateTime":18,"relativeEntities":2188,"label":2189,"description":2190,"key":64,"publicationTags":2191,"standard":18},[],{"EN":60,"VI":60},{"EN":62,"VI":63},[66,67],[70,71],{"id":73,"indexDatabase":2194,"url":84,"indexYears":85,"academicFieldIds":2199,"indexDatabaseRanking":91},{"id":75,"createTime":18,"updateTime":18,"relativeEntities":2195,"label":2196,"description":2197,"key":81,"publicationTags":2198,"standard":18},[],{"EN":78,"VI":78},{"EN":78,"VI":80},[83],[87,88,89,90],{"issue":2201,"pages":2203,"volume":2205},{"VOID":2202},"1",{"VOID":2204},"49-54",{"VOID":1929},{"total":19,"publishYear":1931,"statisticByYear":2207},{},"2001-02-01","2026-07-13T05:04:53.659+00:00",[66,91],[2212,2216,2220,2224,2228,2232,2236,2240,2243,2246,2250,2254,2257,2261,2265,2268,2271,2274,2278,2282,2286,2290,2294,2297],{"id":18,"text":2213,"url":18,"identifiers":2214},"Wargotz, 1987, Myofibroblastoma of the breast. Sixteen cases of a distinctive benign mesenchymal tumor, Am J Surg Pathol, 11, 493, 10.1097\u002F00000478-198707000-00001",{"doi":2215},"10.1097\u002F00000478-198707000-00001",{"id":18,"text":2217,"url":18,"identifiers":2218},"Nascimento, 1996, Solitary fibrous tumor: an ubiquitous neoplasm of mesenchymal differentiation, Adv Anat Pathol, 3, 388, 10.1097\u002F00125480-199611000-00048",{"doi":2219},"10.1097\u002F00125480-199611000-00048",{"id":18,"text":2221,"url":18,"identifiers":2222},"Westra, 1994, Solitary fibrous tumor. Consistent CD34 immunoreactivity and occurrence in the orbit, Am J Surg Pathol, 18, 992, 10.1097\u002F00000478-199410000-00003",{"doi":2223},"10.1097\u002F00000478-199410000-00003",{"id":18,"text":2225,"url":18,"identifiers":2226},"Suster, 1995, Solitary fibrous tumor of soft tissue. A clinicopathologic and immunohistochemical study of 12 cases, Am J Surg Pathol, 19, 1257, 10.1097\u002F00000478-199511000-00005",{"doi":2227},"10.1097\u002F00000478-199511000-00005",{"id":18,"text":2229,"url":18,"identifiers":2230},"Carneiro, 1996, Solitary fibrous tumor of the meninges: a lesion distinct from fibrous meningioma. A clinicopathologic and immunohistochemical study, Am J Clin Pathol, 106, 217, 10.1093\u002Fajcp\u002F106.2.217",{"doi":2231},"10.1093\u002Fajcp\u002F106.2.217",{"id":18,"text":2233,"url":18,"identifiers":2234},"Damiani, 1994, Solitary fibrous tumour (myofibroblastoma) of the breast, Virchows Arch, 425, 89, 10.1007\u002FBF00193955",{"doi":2235},"10.1007\u002FBF00193955",{"id":18,"text":2237,"url":18,"identifiers":2238},"Ali, 1994, Giant myofibroblastoma of the male breast, Am J Surg Pathol, 18, 1170, 10.1097\u002F00000478-199411000-00012",{"doi":2239},"10.1097\u002F00000478-199411000-00012",{"id":18,"text":2241,"url":18,"identifiers":2242},"Rosen, 1993, Tumors of the mammary gland",{},{"id":18,"text":2244,"url":18,"identifiers":2245},"Ordi, 1992, Fine needle aspiration of myofibroblastoma of the breast in a man. A report of two cases, Acta Cytol, 36, 194",{},{"id":18,"text":2247,"url":18,"identifiers":2248},"Amin, 1993, Fine-needle aspiration cytologic study of myofibroblastoma of the breast. Immunohistochemical and ultrastructural findings, Am J Clin Pathol, 99, 593, 10.1093\u002Fajcp\u002F99.5.593",{"doi":2249},"10.1093\u002Fajcp\u002F99.5.593",{"id":18,"text":2251,"url":18,"identifiers":2252},"Begin, 1991, Myogenic stromal tumor of the male breast (so-called myofibroblastoma), Ultrastruct Pathol, 15, 613, 10.3109\u002F01913129109023191",{"doi":2253},"10.3109\u002F01913129109023191",{"id":18,"text":2255,"url":18,"identifiers":2256},"Rebner, 1993, Myofibroblastoma of the male breast, Breast Dis, 6, 157",{},{"id":18,"text":2258,"url":18,"identifiers":2259},"Witkin, 1991, Solitary fibrous tumor of the upper respiratory tract. A report of six cases, Am J Surg Pathol, 15, 842, 10.1097\u002F00000478-199109000-00004",{"doi":2260},"10.1097\u002F00000478-199109000-00004",{"id":18,"text":2262,"url":18,"identifiers":2263},"Van de Rijn, 1994, Expression of CD34 by solitary fibrous tumors of the pleura, mediastinum, and lung, Am J Surg Pathol, 18, 814, 10.1097\u002F00000478-199408000-00008",{"doi":2264},"10.1097\u002F00000478-199408000-00008",{"id":18,"text":2266,"url":18,"identifiers":2267},"Yamazaki, 1995, Ultrastructural and immunohistochemical observations on intralobular fibroblasts of human breast, with observations on the CD34 antigen, J Submicrosc Cytol Pathol, 27, 309",{},{"id":18,"text":2269,"url":18,"identifiers":2270},"Fukunaga, 1997, Myofibroblastoma of the breast with diverse differentiations, Arch Pathol Lab Med, 121, 599",{},{"id":18,"text":2272,"url":18,"identifiers":2273},"Hamele-Bena, 1996, Uncommon presentation of mammary myofibroblastoma, Mod Pathol, 9, 786",{},{"id":18,"text":2275,"url":18,"identifiers":2276},"Silverman, 1996, Mammary fibroadenoma and some phyllodes tumour stroma are composed of CD34+ fibroblasts and factor XIIIa+ dendrophages, Histopathology, 29, 411, 10.1046\u002Fj.1365-2559.1996.d01-510.x",{"doi":2277},"10.1046\u002Fj.1365-2559.1996.d01-510.x",{"id":18,"text":2279,"url":18,"identifiers":2280},"Schmitt-Graff, 1994, Heterogeneity of myofibroblast phenotypic features: an example of fibroblastic cell plasticity, Virchows Arch, 425, 3, 10.1007\u002FBF00193944",{"doi":2281},"10.1007\u002FBF00193944",{"id":18,"text":2283,"url":18,"identifiers":2284},"Thomas, 1997, Mammary myofibroblastoma with leiomyomatous differentiation, Am J Clin Pathol, 107, 52, 10.1093\u002Fajcp\u002F107.1.52",{"doi":2285},"10.1093\u002Fajcp\u002F107.1.52",{"id":18,"text":2287,"url":18,"identifiers":2288},"Witkin, 1989, Solitary fibrous tumor of the mediastinum. A report of 14 cases, Am J Surg Pathol, 13, 547, 10.1097\u002F00000478-198907000-00002",{"doi":2289},"10.1097\u002F00000478-198907000-00002",{"id":18,"text":2291,"url":18,"identifiers":2292},"Lee, 1993, Myofibroblastoma of breast: an immunohistochemical study, Histopathology, 22, 75, 10.1111\u002Fj.1365-2559.1993.tb00074.x",{"doi":2293},"10.1111\u002Fj.1365-2559.1993.tb00074.x",{"id":18,"text":2295,"url":18,"identifiers":2296},"Julien, 1994, Myofibroblastoma of the breast. Report of 8 cases [French], Ann Pathol, 14, 143",{},{"id":18,"text":2298,"url":18,"identifiers":2299},"Goodlad, 1991, Solitary fibrous tumour arising at unusual sites: analysis of a series, Histopathology, 19, 515, 10.1111\u002Fj.1365-2559.1991.tb01499.x",{"doi":2300},"10.1111\u002Fj.1365-2559.1991.tb01499.x",{"id":2302,"createTime":2303,"updateTime":2304,"relativeEntities":2305,"slug":2306,"properties":2307,"entityType":109,"verifyStatus":110,"verifyTime":2314,"verifyNote":112,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":2315,"fullTextUrl":18,"authors":2316,"publicationType":265,"publisherRelationship":2442,"citationCount":2491,"citationInfo":2492,"publishDate":2495,"publishYear":2493,"citationAnalyzeStatus":320,"lastCitationAnalyze":2496,"indexDatabases":2497,"openAccess":18,"references":2498,"isForceReanalyzing":399},"0a11e616-a6e9-47f5-802e-dd30344fb951","2023-12-06T09:56:03.840+00:00","2026-07-12T19:01:14.084+00:00",[],"The-role-of-CDK4-6-inhibitors-in-older-and-younger-patients-with-breast-cancer-A-systematic-review-and-meta-analysis",{"title":2308,"gsPaper":2310,"doi":2312},{"EN":2309},"The role of CDK4\u002F6 inhibitors in older and younger patients with breast cancer: A systematic review and meta-analysis",{"VOID":2311},"[\"5643732952778456301\"]",{"VOID":2313},"10.1016\u002Fj.breast.2023.05.002","2024-05-03T02:36:29.205+00:00","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0960977623004599",[2317,2332,2347,2362,2375,2388,2401,2414,2429],{"id":2318,"sortIndex":19,"researcher":18,"roles":2319,"affiliations":2320,"properties":2329,"displayName":2331,"givenName":18,"familyName":18},"ffd29bcd-c94f-40d6-8840-6215849a5d91",[118],[2321],{"id":2322,"sortIndex":19,"affiliation":2323,"properties":18},"982abe22-0ee9-4d58-820b-33317eafa804",{"id":2322,"createTime":18,"updateTime":18,"relativeEntities":2324,"slug":18,"properties":2325,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":2328,"statistic":18},[],{"title":2326},{"VI":2327},"Oncology Unit, ASST Bergamo ovest, Treviglio (BG), Italy",[],{"title":2330},{"VI":2331},"Fausto Petrelli",{"id":2333,"sortIndex":135,"researcher":18,"roles":2334,"affiliations":2335,"properties":2342,"displayName":2344,"givenName":18,"familyName":18},"1c0cab07-4f0e-48a1-ad69-747c28f138a4",[118],[2336],{"id":2322,"sortIndex":19,"affiliation":2337,"properties":18},{"id":2322,"createTime":18,"updateTime":18,"relativeEntities":2338,"slug":18,"properties":2339,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":2341,"statistic":18},[],{"title":2340},{"VI":2327},[],{"title":2343,"gsAuthor":2345},{"VI":2344},"Lorenzo Dottorini",{"VOID":2346},"[\"M-Cph3oAAAAJ\"]",{"id":2348,"sortIndex":151,"researcher":18,"roles":2349,"affiliations":2350,"properties":2359,"displayName":2361,"givenName":18,"familyName":18},"bde75293-de49-4081-aa63-e4cb8e4c96e1",[118],[2351],{"id":2352,"sortIndex":19,"affiliation":2353,"properties":18},"7167e5f3-4778-41dc-92cf-4a9ca280b729",{"id":2352,"createTime":18,"updateTime":18,"relativeEntities":2354,"slug":18,"properties":2355,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":2358,"statistic":18},[],{"title":2356},{"VI":2357},"IRCCS Istituto Romagnolo per Lo Studio Dei Tumori (IRST) “Dino Amadori”, Meldola, Italy",[],{"title":2360},{"VI":2361},"Giandomenico Di Menna",{"id":2363,"sortIndex":167,"researcher":18,"roles":2364,"affiliations":2365,"properties":2372,"displayName":2374,"givenName":18,"familyName":18},"6d069dd6-475a-41df-8185-2802796e4a5c",[118],[2366],{"id":2322,"sortIndex":19,"affiliation":2367,"properties":18},{"id":2322,"createTime":18,"updateTime":18,"relativeEntities":2368,"slug":18,"properties":2369,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":2371,"statistic":18},[],{"title":2370},{"VI":2327},[],{"title":2373},{"VI":2374},"Karen Borgonovo",{"id":2376,"sortIndex":183,"researcher":18,"roles":2377,"affiliations":2378,"properties":2385,"displayName":2387,"givenName":18,"familyName":18},"f507560c-1649-4e0d-b87a-40fee2aeb81c",[118],[2379],{"id":2322,"sortIndex":19,"affiliation":2380,"properties":18},{"id":2322,"createTime":18,"updateTime":18,"relativeEntities":2381,"slug":18,"properties":2382,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":2384,"statistic":18},[],{"title":2383},{"VI":2327},[],{"title":2386},{"VI":2387},"Maria Chiara Parati",{"id":2389,"sortIndex":197,"researcher":18,"roles":2390,"affiliations":2391,"properties":2398,"displayName":2400,"givenName":18,"familyName":18},"6b2fe6f5-fd87-4e7b-9513-7519335b6e2a",[118],[2392],{"id":2322,"sortIndex":19,"affiliation":2393,"properties":18},{"id":2322,"createTime":18,"updateTime":18,"relativeEntities":2394,"slug":18,"properties":2395,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":2397,"statistic":18},[],{"title":2396},{"VI":2327},[],{"title":2399},{"VI":2400},"Carmen Giusy Rea",{"id":2402,"sortIndex":211,"researcher":18,"roles":2403,"affiliations":2404,"properties":2411,"displayName":2413,"givenName":18,"familyName":18},"438191ca-2952-4f8e-bc36-b9a92df8e638",[118],[2405],{"id":2322,"sortIndex":19,"affiliation":2406,"properties":18},{"id":2322,"createTime":18,"updateTime":18,"relativeEntities":2407,"slug":18,"properties":2408,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":2410,"statistic":18},[],{"title":2409},{"VI":2327},[],{"title":2412},{"VI":2413},"Mara Ghilardi",{"id":2415,"sortIndex":225,"researcher":18,"roles":2416,"affiliations":2417,"properties":2426,"displayName":2428,"givenName":18,"familyName":18},"f0c0b74f-07dc-4325-ac6f-b129f282f9ad",[118],[2418],{"id":2419,"sortIndex":19,"affiliation":2420,"properties":18},"fbe8eec1-1199-4d72-a077-11785187161d",{"id":2419,"createTime":18,"updateTime":18,"relativeEntities":2421,"slug":18,"properties":2422,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":2425,"statistic":18},[],{"title":2423},{"VI":2424},"Oncology Unit, Casa di cura Igea, Milano, Italy",[],{"title":2427},{"VI":2428},"Antonio Ghidini",{"id":2430,"sortIndex":239,"researcher":18,"roles":2431,"affiliations":2432,"properties":2439,"displayName":2441,"givenName":18,"familyName":18},"7dda5b35-4aef-4ac2-93cb-9463ae3f46cf",[118],[2433],{"id":2322,"sortIndex":19,"affiliation":2434,"properties":18},{"id":2322,"createTime":18,"updateTime":18,"relativeEntities":2435,"slug":18,"properties":2436,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":2438,"statistic":18},[],{"title":2437},{"VI":2327},[],{"title":2440},{"VI":2441},"Andrea Luciani",{"url":2315,"publisher":2443,"properties":2486},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":2444,"slug":10,"properties":2445,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":2448,"manageAffiliations":2465,"indexDatabases":2471,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":2446,"title":2447},{"VOID":13},{"EN":15},[2449,2453,2457,2461],{"id":22,"createTime":18,"updateTime":18,"relativeEntities":2450,"label":2451,"description":2452,"parentId":18,"standard":18,"scholarHubFieldId":18},[],{"EN":25},{},{"id":28,"createTime":18,"updateTime":18,"relativeEntities":2454,"label":2455,"description":2456,"parentId":18,"standard":18,"scholarHubFieldId":18},[],{"EN":31},{},{"id":34,"createTime":18,"updateTime":18,"relativeEntities":2458,"label":2459,"description":2460,"parentId":18,"standard":18,"scholarHubFieldId":18},[],{"EN":37},{},{"id":40,"createTime":18,"updateTime":18,"relativeEntities":2462,"label":2463,"description":2464,"parentId":18,"standard":18,"scholarHubFieldId":18},[],{"EN":43},{},[2466],{"id":47,"createTime":18,"updateTime":18,"relativeEntities":2467,"slug":18,"properties":2468,"entityType":18,"verifyStatus":18,"verifyTime":18,"verifyNote":18,"languages":18,"translateLanguages":18,"viewCount":18,"url":18,"parentIds":2470,"statistic":18},[],{"title":2469},{"EN":51},[],[2472,2479],{"id":55,"indexDatabase":2473,"url":68,"indexYears":18,"academicFieldIds":2478,"indexDatabaseRanking":18},{"id":57,"createTime":18,"updateTime":18,"relativeEntities":2474,"label":2475,"description":2476,"key":64,"publicationTags":2477,"standard":18},[],{"EN":60,"VI":60},{"EN":62,"VI":63},[66,67],[70,71],{"id":73,"indexDatabase":2480,"url":84,"indexYears":85,"academicFieldIds":2485,"indexDatabaseRanking":91},{"id":75,"createTime":18,"updateTime":18,"relativeEntities":2481,"label":2482,"description":2483,"key":81,"publicationTags":2484,"standard":18},[],{"EN":78,"VI":78},{"EN":78,"VI":80},[83],[87,88,89,90],{"pages":2487,"volume":2489},{"VOID":2488},"138-142",{"VOID":2490},"71",22,{"total":2491,"publishYear":2493,"statisticByYear":2494},2023,{"2023":151,"2024":183,"2025":1568,"2026":167},"2023-10-01","2026-07-12T19:01:14.083+00:00",[66,91],[2499,2506,2512,2518,2524,2530,2533,2540,2546,2552,2561,2568,2574,2577,2585,2589,2595,2603,2609,2618,2622,2629,2635,2644,2652,2660,2667,2675,2684,2690,2697,2706,2713,2719,2728,2734,2741],{"id":18,"text":2500,"url":2501,"identifiers":2502},"Giaquinto, 2022, Breast cancer statistics, 2022, Ca - Cancer J Clin, 72, 524, 10.3322\u002Fcaac.21754","https:\u002F\u002Fdoi.org\u002F10.1007\u002F978-1-4614-5647-6_1",{"mag":2503,"openalex":2504,"doi":2505},"2220945839","W2220945839","10.1007\u002F978-1-4614-5647-6_1",{"id":2507,"text":2508,"url":2509,"identifiers":2510},"a08457f9-ac33-469a-93d7-b778d4bb4de6","Page, 2021, The PRISMA 2020 statement: an updated guideline for reporting systematic reviews, Syst Rev, 10, 89, 10.1186\u002Fs13643-021-01626-4","https:\u002F\u002Fsystematicreviewsjournal.biomedcentral.com\u002Farticles\u002F10.1186\u002Fs13643-021-01626-4",{"doi":2511},"10.1186\u002Fs13643-021-01626-4",{"id":2513,"text":2514,"url":2515,"identifiers":2516},"2ea02dc0-3a06-4d1e-aefc-2ff0d53dbf9f","Sterne, 2019, RoB 2: a revised tool for assessing risk of bias in randomised trials, BMJ, 366, l4898, 10.1136\u002Fbmj.l4898","https:\u002F\u002Fwww.bmj.com\u002Flookup\u002Fdoi\u002F10.1136\u002Fbmj.l4898",{"doi":2517},"10.1136\u002Fbmj.l4898",{"id":2519,"text":2520,"url":2521,"identifiers":2522},"a6d1fd1d-56cc-4b3c-a76f-3c837aa7952e","Higgins, 2003, Measuring inconsistency in meta-analyses, BMJ, 327, 557, 10.1136\u002Fbmj.327.7414.557","https:\u002F\u002Fwww.bmj.com\u002Flookup\u002Fdoi\u002F10.1136\u002Fbmj.327.7414.557",{"doi":2523},"10.1136\u002Fbmj.327.7414.557",{"id":2525,"text":2526,"url":2527,"identifiers":2528},"8d9ae324-e3b2-455c-a179-c2548013ff36","DerSimonian, 1986, Meta-analysis in clinical trials, Contr Clin Trials, 7, 177, 10.1016\u002F0197-2456(86)90046-2","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002F0197245686900462",{"doi":2529},"10.1016\u002F0197-2456(86)90046-2",{"id":18,"text":2531,"url":18,"identifiers":2532},"2020",{},{"id":18,"text":2534,"url":2535,"identifiers":2536},"Albanell, 2022, Randomized phase II study of fulvestrant plus palbociclib or placebo in endocrine-sensitive, hormone receptor-positive\u002FHER2–advanced breast cancer: geicam\u002F2014–12 (FLIPPER), Eur J Cancer, 161, 26, 10.1016\u002Fj.ejca.2021.11.010","https:\u002F\u002Fdoi.org\u002F10.1016\u002Fj.ejca.2021.11.010",{"openalex":2537,"pm":2538,"doi":2539},"W4200357248","34902765","10.1016\u002Fj.ejca.2021.11.010",{"id":2541,"text":2542,"url":2543,"identifiers":2544},"4ae52b6e-d8f3-4c5b-94d9-625d943382c5","Finn, 2020, Overall survival results from the randomized phase 2 study of palbociclib in combination with letrozole versus letrozole alone for first-line treatment of ER+\u002FHER2− advanced breast cancer (PALOMA-1, TRIO-18), Breast Cancer Res Treat, 183, 419, 10.1007\u002Fs10549-020-05755-7","https:\u002F\u002Flink.springer.com\u002F10.1007\u002Fs10549-020-05755-7",{"doi":2545},"10.1007\u002Fs10549-020-05755-7",{"id":18,"text":2547,"url":2548,"identifiers":2549},"Goetz, 2022, LBA15 MONARCH 3: interim overall survival (OS) results of abemaciclib plus a nonsteroidal aromatase inhibitor (NSAI) in patients (pts) with HR+, HER2- advanced breast cancer (ABC), Ann Oncol, 33, S1384, 10.1016\u002Fj.annonc.2022.08.009","https:\u002F\u002Fdoi.org\u002F10.1016\u002Fj.annonc.2022.08.009",{"openalex":2550,"doi":2551},"W4297986229","10.1016\u002Fj.annonc.2022.08.009",{"id":18,"text":2553,"url":2554,"identifiers":2555},"Goetz, 2021, Safety and efficacy of abemaciclib plus endocrine therapy in older patients with hormone receptor-positive\u002Fhuman epidermal growth factor receptor 2-negative advanced breast cancer: an age-specific subgroup analysis of MONARCH 2 and 3 trials, Breast Cancer Res Treat, 186, 417, 10.1007\u002Fs10549-020-06029-y","https:\u002F\u002Fdoi.org\u002F10.1007\u002Fs10549-020-06029-y",{"mag":2556,"pmc":2557,"openalex":2558,"pm":2559,"doi":2560},"3120214437","7990838","W3120214437","33392835","10.1007\u002Fs10549-020-06029-y",{"id":18,"text":2562,"url":2563,"identifiers":2564},"Hortobagyi, 2022, Overall survival with ribociclib plus letrozole in advanced breast cancer, N Engl J Med, 386, 942, 10.1056\u002FNEJMoa2114663","https:\u002F\u002Fdoi.org\u002F10.1056\u002Fnejmoa2114663",{"openalex":2565,"pm":2566,"doi":2567},"W4221085715","35263519","10.1056\u002Fnejmoa2114663",{"id":2569,"text":2570,"url":2571,"identifiers":2572},"a8889aee-2bbb-4fd1-a615-7d588c37a901","Rugo, 2018, Palbociclib plus endocrine therapy in older women with HR+\u002FHER2– advanced breast cancer: a pooled analysis of randomised PALOMA clinical studies, Eur J Cancer, 101, 123, 10.1016\u002Fj.ejca.2018.05.017","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0959804918309080",{"doi":2573},"10.1016\u002Fj.ejca.2018.05.017",{"id":350,"text":2575,"url":352,"identifiers":2576},"Slamon, 2021, Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the phase III randomized MONALEESA-3 trial: updated overall survival, Ann Oncol",{"doi":354},{"id":18,"text":2578,"url":2579,"identifiers":2580},"Slamon, 2018, Phase III randomized study of ribociclib and fulvestrant in hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: MONALEESA-3, J Clin Oncol, 36, 2465, 10.1200\u002FJCO.2018.78.9909","https:\u002F\u002Fdoi.org\u002F10.1200\u002Fjco.2018.78.9909",{"mag":2581,"openalex":2582,"pm":2583,"doi":2584},"2805575723","W2805575723","29860922","10.1200\u002Fjco.2018.78.9909",{"id":18,"text":2586,"url":18,"identifiers":2587},"Sledge, 2020, The effect of abemaciclib plus fulvestrant on overall survival in hormone receptor-positive, ERBB2-negative breast cancer that progressed on endocrine therapy - MONARCH 2: a randomized clinical trial, JAMA Oncol, 6, 116, 10.1001\u002Fjamaoncol.2019.4782",{"doi":2588},"10.1001\u002Fjamaoncol.2019.4782",{"id":2590,"text":2591,"url":2592,"identifiers":2593},"8b427737-6dfb-4757-adb3-26b0787a8110","Sonke, 2018, Ribociclib with letrozole vs letrozole alone in elderly patients with hormone receptor-positive, HER2-negative breast cancer in the randomized MONALEESA-2 trial, Breast Cancer Res Treat, 167, 659, 10.1007\u002Fs10549-017-4523-y","http:\u002F\u002Flink.springer.com\u002F10.1007\u002Fs10549-017-4523-y",{"doi":2594},"10.1007\u002Fs10549-017-4523-y",{"id":18,"text":2596,"url":2597,"identifiers":2598},"Turner, 2018, Overall survival with palbociclib and fulvestrant in advanced breast cancer, N Engl J Med, 379, 1926, 10.1056\u002FNEJMoa1810527","https:\u002F\u002Fdoi.org\u002F10.1056\u002Fnejmoa1810527",{"mag":2599,"openalex":2600,"pm":2601,"doi":2602},"2896846857","W2896846857","30345905","10.1056\u002Fnejmoa1810527",{"id":2604,"text":2605,"url":2606,"identifiers":2607},"836b7f66-621a-431e-8daf-9db490c30465","Xu, 2022, Palbociclib plus letrozole versus placebo plus letrozole in Asian postmenopausal women with oestrogen receptor–positive\u002Fhuman epidermal growth factor receptor 2–negative advanced breast cancer: primary results from PALOMA-4, Eur J Cancer, 175, 236, 10.1016\u002Fj.ejca.2022.08.012","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0959804922004890",{"doi":2608},"10.1016\u002Fj.ejca.2022.08.012",{"id":18,"text":2610,"url":2611,"identifiers":2612},"Zhang, 2020, MONARCH plus: abemaciclib plus endocrine therapy in women with HR+\u002FHER2- advanced breast cancer: the multinational randomized phase III study, Ther Adv Med Oncol, 12, 10.1177\u002F1758835920963925","https:\u002F\u002Fdoi.org\u002F10.1177\u002F1758835920963925",{"mag":2613,"pmc":2614,"openalex":2615,"pm":2616,"doi":2617},"3093770108","7586037","W3093770108","33149768","10.1177\u002F1758835920963925",{"id":18,"text":2619,"url":18,"identifiers":2620},"Finn, 2022, J Clin Oncol, 40, LBA1003, 10.1200\u002FJCO.2022.40.17_suppl.LBA1003",{"doi":2621},"10.1200\u002FJCO.2022.40.17_suppl.LBA1003",{"id":18,"text":2623,"url":2624,"identifiers":2625},"Burstein, 2021, Endocrine treatment and targeted therapy for hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer: ASCO guideline update, J Clin Oncol, 39, 3959, 10.1200\u002FJCO.21.01392","https:\u002F\u002Fdoi.org\u002F10.1200\u002Fjco.21.01392",{"openalex":2626,"pm":2627,"doi":2628},"W4226361682","34324367","10.1200\u002Fjco.21.01392",{"id":2630,"text":2631,"url":2632,"identifiers":2633},"5cec709e-69c1-4590-bd63-1bd52511dd11","Giuliano, 2019, Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis, Lancet Oncol, 20, 1360, 10.1016\u002FS1470-2045(19)30420-6","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1470204519304206",{"doi":2634},"10.1016\u002Fs1470-2045(19)30420-6",{"id":18,"text":2636,"url":2637,"identifiers":2638},"Clifton, 2019, Progression-free survival (PFS) and toxicities of palbociclib in a geriatric population, Breast Cancer Res Treat, 175, 667, 10.1007\u002Fs10549-019-05181-4","https:\u002F\u002Fdoi.org\u002F10.1007\u002Fs10549-019-05181-4",{"mag":2639,"pmc":2640,"openalex":2641,"pm":2642,"doi":2643},"2920014560","6535110","W2920014560","30835017","10.1007\u002Fs10549-019-05181-4",{"id":18,"text":2645,"url":2646,"identifiers":2647},"Wilkie, 2020, Progression-free survival for real-world use of palbociclib in hormone receptor-positive metastatic breast cancer, Clin Breast Cancer, 20, 33, 10.1016\u002Fj.clbc.2019.06.010","https:\u002F\u002Fdoi.org\u002F10.1016\u002Fj.clbc.2019.06.010",{"mag":2648,"openalex":2649,"pm":2650,"doi":2651},"2959831705","W2959831705","31451366","10.1016\u002Fj.clbc.2019.06.010",{"id":18,"text":2653,"url":2654,"identifiers":2655},"Olazagasti, 2023, A deep dive into CDK4\u002F6 inhibitors: evaluating real world toxicities and treatment paradigms in the elderly population, J Oncol Pharm Pract, 29, 14, 10.1177\u002F10781552211050106","https:\u002F\u002Fdoi.org\u002F10.1177\u002F10781552211050106",{"mag":2656,"openalex":2657,"pm":2658,"doi":2659},"3206582662","W3206582662","34665067","10.1177\u002F10781552211050106",{"id":18,"text":2661,"url":2662,"identifiers":2663},"Low, 2022, Real-world outcomes from use of CDK4\u002F6 inhibitors in the management of advanced\u002Fmetastatic breast cancer in Asia, Ther Adv Med Oncol, 14, 10.1177\u002F17588359221139678","https:\u002F\u002Fdoi.org\u002F10.1177\u002F17588359221139678",{"openalex":2664,"pm":2665,"doi":2666},"W4312209924","36570409","10.1177\u002F17588359221139678",{"id":18,"text":2668,"url":2669,"identifiers":2670},"Howie, 2019, Outcomes of older women with hormone receptor-positive, human epidermal growth factor receptor-negative metastatic breast cancer treated with a CDK4\u002F6 inhibitor and an aromatase inhibitor: an FDA pooled analysis, J Clin Oncol, 37, 3475, 10.1200\u002FJCO.18.02217","https:\u002F\u002Fdoi.org\u002F10.1200\u002Fjco.18.02217",{"mag":2671,"openalex":2672,"pm":2673,"doi":2674},"2975749949","W2975749949","31560580","10.1200\u002Fjco.18.02217",{"id":18,"text":2676,"url":2677,"identifiers":2678},"Mohile, 2018, Practical assessment and management of vulnerabilities in older patients receiving chemotherapy: ASCO guideline for geriatric Oncology, J Clin Oncol, 36, 2326, 10.1200\u002FJCO.2018.78.8687","https:\u002F\u002Fdoi.org\u002F10.1200\u002Fjco.2018.78.8687",{"mag":2679,"pmc":2680,"openalex":2681,"pm":2682,"doi":2683},"2804780558","6063790","W2804780558","29782209","10.1200\u002Fjco.2018.78.8687",{"id":2685,"text":2686,"url":2687,"identifiers":2688},"db650f69-53be-49d5-be19-a221ef57ed26","Rugo, 2018, Impact of palbociclib plus letrozole on patient-reported health-related quality of life: results from the PALOMA-2 trial, Ann Oncol, 29, 888, 10.1093\u002Fannonc\u002Fmdy012","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0923753419454628",{"doi":2689},"10.1093\u002Fannonc\u002Fmdy012",{"id":18,"text":2691,"url":2692,"identifiers":2693},"Kaufman, 2018, Health-related quality of life (HRQoL) in MONARCH 2: abemaciclib plus fulvestrant in women with HR+, HER2- advanced breast cancer (ABC) who progressed on endocrine therapy, J Clin Oncol, 36, 1049, 10.1200\u002FJCO.2018.36.15_suppl.1049","https:\u002F\u002Fdoi.org\u002F10.1200\u002Fjco.2018.36.15_suppl.1049",{"mag":2694,"openalex":2695,"doi":2696},"2806055242","W2806055242","10.1200\u002Fjco.2018.36.15_suppl.1049",{"id":18,"text":2698,"url":2699,"identifiers":2700},"Battisti, 2018, Use of cyclin-dependent kinase 4\u002F6 (CDK4\u002F6) inhibitors in older patients with ER-positive HER2-negative breast cancer: young International Society of Geriatric Oncology review paper, Ther Adv Med Oncol, 10, 10.1177\u002F1758835918809610","https:\u002F\u002Fdoi.org\u002F10.1177\u002F1758835918809610",{"mag":2701,"pmc":2702,"openalex":2703,"pm":2704,"doi":2705},"2901884329","6249663","W2901884329","30479671","10.1177\u002F1758835918809610",{"id":18,"text":2707,"url":2708,"identifiers":2709},"Mastrantoni, 2023, The likelihood of being helped or harmed as a patient-centred tool to assess cyclin dependent kinase 4\u002F6 inhibitors clinical impact and safety in metastatic breast cancer: a systematic review and sensitivity-analysis, EClinicalMedicine, 56, 10.1016\u002Fj.eclinm.2023.101824","https:\u002F\u002Fdoi.org\u002F10.1016\u002Fj.eclinm.2023.101824",{"openalex":2710,"pm":2711,"doi":2712},"W4318542396","36713467","10.1016\u002Fj.eclinm.2023.101824",{"id":2714,"text":2715,"url":2716,"identifiers":2717},"77a10f2f-9ab6-49fd-96a8-48aef5a5d06d","DeMichele, 2021, Comparative effectiveness of first-line palbociclib plus letrozole versus letrozole alone for HR+\u002FHER2- metastatic breast cancer in US real-world clinical practice, Breast Cancer Res, 23, 37, 10.1186\u002Fs13058-021-01409-8","https:\u002F\u002Fbreast-cancer-research.biomedcentral.com\u002Farticles\u002F10.1186\u002Fs13058-021-01409-8",{"doi":2718},"10.1186\u002Fs13058-021-01409-8",{"id":18,"text":2720,"url":2721,"identifiers":2722},"De Laurentiis, 2021, Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded population [published correction appears in Breast Cancer Res Treat. 2021 Oct 8;:], Breast Cancer Res Treat, 189, 689, 10.1007\u002Fs10549-021-06334-0","https:\u002F\u002Fdoi.org\u002F10.1007\u002Fs10549-021-06334-0",{"mag":2723,"pmc":2724,"openalex":2725,"pm":2726,"doi":2727},"3196278183","8505291","W3196278183","34625861","10.1007\u002Fs10549-021-06334-0",{"id":2729,"text":2730,"url":2731,"identifiers":2732},"6ce37b35-8d3a-46a2-ae83-74d294674042","Mycock, 2022, Real-world treatment patterns and clinical outcomes associated with palbociclib combination therapy: a multinational, pooled analysis from the ibrance real world insights study, Clin Therapeut, 44, 1588, 10.1016\u002Fj.clinthera.2022.11.004","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0149291822003794",{"doi":2733},"10.1016\u002Fj.clinthera.2022.11.004",{"id":18,"text":2735,"url":2736,"identifiers":2737},"Price, 2022, Real world incidence and management of adverse events in patients with HR+, HER2- metastatic breast cancer receiving CDK4 and 6 inhibitors in a United States community setting, Curr Med Res Opin, 38, 1319, 10.1080\u002F03007995.2022.2073122","https:\u002F\u002Fdoi.org\u002F10.1080\u002F03007995.2022.2073122",{"openalex":2738,"pm":2739,"doi":2740},"W4229443358","35535675","10.1080\u002F03007995.2022.2073122",{"id":18,"text":2742,"url":2743,"identifiers":2744},"Goyal, 2023, Overall survival associated with CDK4\u002F6 inhibitors in patients with HR+\u002FHER2- metastatic breast cancer in the United States: a SEER-Medicare population-based study, Cancer, 129, 1051, 10.1002\u002Fcncr.34675","https:\u002F\u002Fdoi.org\u002F10.1002\u002Fcncr.34675",{"openalex":2745,"pm":2746,"doi":2747},"W4319826645","36760031","10.1002\u002Fcncr.34675"]